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The neona ta l  a nemia of ra ts ,  swi ne a nd huma ns is a c ommon phy­
s i olog i ca l  phenomenon. The progre s s i on of the a n emia i s  subjected to 
wide  ind i vidua l  varia tion  and usua l l y  pr ogre sses  invers e l y  to the 
dam's nutr i ti on . The ne ona te 's nutr i ti on a lso  inverse l y  a l ters the 
anemi c  peri od . The neonc:i.ta l anemia doe s not bec ome a ppa rent until  
three  to five da ys pos tpartum . The ne ona te demons tra te s a fa s t  grow­
ing per i od f o l l owing pa rtuiti on wi th on l y  sma l l  s to r a g e  ir on reserves 
a va i l a b l e  f or the deve l oping tissues . Consequently , there is  a 
decrea s e  in  iron ava i la bi li ty for norma l hemog l obin s yn thes i s  a nd 
ma ture erythrocyte for ma tion . The anemic  neona te bec ome s more sus­
ceptibl e to disea se which ma y termi na te in death. If the ne ona te 
survive s the a nemic  per iod ,  there is  a gra dua l re turn towa rds norma l. 
The econom i ca l c ons idera tions c oncern commerc ia l l ives tock  growers ; 
howe ver , the he c:il th of  huma n l ife is  man i fested a s  we l l . 
Decrea sed pac ked c e l l  volume a nd hemog l obin  c onc entra tion found 
in neonata l anemia  ind i c a te inadequa te erythropo ieti c  respon se  a nd 
hemog l obin synthe s i s  ( Swanson , 1964 ) . The de la yed a n em i c  symptoms 
may resul t from ma terna l pla centa l  tr ansport of  hemog lobi n  prec ursors 
and erythropoi etic  s timu l i  to the fetus . 
The resulting hemogram def i c i enc ies ma y pos s ibl y be al l ev ia ted 
by prepartum ma terna l trea tment and/or postpa rtum neona te trea tment . 
Postpa rtum neona tal trea tments ma y  add s tr es s e s  upon the newborn, 
thus enhanc ing the a nemic c onditi on. 
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The pr ima ry chemi ca l subs ta nc e concer ned with i r on incorp orat i on 
i nto the erythron and hemogl obin synthesi s  is the not  ye t fu ll y 
characterized hormone , erythropoietin .  Several chemica l s  are being 
eva luated a t  the present which may suces sful ly  enhance  the neonata l 
hernogram parameters. Dibenzyli ne, a promi si ng drug, e l i c i ts serum 
iron leve l change s  and atropine increa ses gastro intest inal iron  
absorpt i on ( Schade , Fe l sher and Conr ad , 1969). 
The exper imenta l st udy objec tives were to observe sel ected hemo­
gr am pa rameters in pregnant rabbi ts a nd fetuses  f ol l owi ng pre p artum 
tre at me nts  of atrop ine , dibenzyl ine and injectab le  iron dextran .  
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REVIEW OF L ITERATURE 
I .  Control of Erythropoietin Produc t i on 
Hormona l  Control 
F i sher (1968) cited  pioneering work by Carnot and Def l a ndre who 
postula ted  a humera l fa Gtor contro l l ing erythropoies i s  a nd tha t this 
fa ctor, "he mopoie t i n", is secreted into the bl ood strea m d irectl y to 
stimu la te bone marrow .Led blood cel l (HBC) forma t i on.  They  showed 
tha t norma l  ra bbits inj ected with anemi c  donor ra bb i t  pla sma demon­
stra ted i ncrea sed red c e l l  counts . Bonsdorff a nd Ja l ivisto  (1968 ) 
bel i eved th is  hor mone pr i ma ri l y  c ontr ol l ed red c e l l produc t i on a nd 
na med · i t  erythropo i et in.  
Re i s s ma nn (1950) demonstrated  poss ibl e humera l e rythropoi etic  
control  u s ing para bioti c  rats . Exposure of  one  member to redu c ed 
oxygen partia l pre s sure resul ted in erythropo iet ic s t i mu l a t i on of 
both .  He suggested humora l a gent tra nsport across the pa ra bi ot i c  
junct ion fro m  the hypox i c  a n i ma l . Ers l ev (1953) inj ec ted a nemic  ra b­
bi t pl a sma into norma l rec i pi ents and conf irmed Re i s s ma nn 's results • .  
I I �  Production S ites of  Erythropo i et in 
Orga n exc i s i on and orga n extract ion hormone a nalys i s  were the 
early  atte mpts to l oca te erythropo ietin produ ction s i tes .  
Gordon , P i l i ero a nd Ta nnenbaum (1955) studi ed a ne mi c  ra bb i t  
blood for erythr opoietic  a c tivity a nd found increased r e t i c ul oc yte 
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counts , RBC counts , hemogl obin c oncentra t i on a nd pa cked c ell volumes  
in rec ipient a n ima l s .  Gord on et aL ( 1956 ) ut i l i zed  anem ic ra bbit 
extra cts of  s pl een , thymus ,  l ung , bra in ,  skin , pan cr ea s ,  s ke l eta l 
mu sc l e, bone ma rrow , pla sma a nd pa cked b l ood ce l ls , o f  whi ch onl y  
pl a sma d e rnor.s trated erythropoieti c  a ct ivity i n  normal ra ts . 
Extens ive inve stiga tions util iz ing hypophyse ctomi z ed a nd a d­
rena l e c tomize d  rats have c l e arly  demonstra ted tha t the pitu itary 
g la nd is not the s i te of  erytnropoietin product i on . Va n Dyke (1959) 
dernonstra  ted tha t  a drenocorticotrophic hormone from the a ntex·i or 
pitu i tary exerts its a c tions secondar i ly through the a drenal cortex . 
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The ma j or erythr opo i etin  production  s ite i s  n ow thought to  be 
wi thi n  the k i dney .  Ja cobson f�t .?.1-.· (1957 ) cl ear l v  d emons tra ted tha t 
coba l t a nd bl eeding fa i l ed to e lic it  a n  erythropo i et i c  response in 
b i l a tera l l y nephrectomi zed ra ts a nd ra bbi ts. B i la tera l ly nephre c ­
tomi zed dog s  demons tra ted decrea sed bone ma rrow erythrobl a sts , de­
crea s ed pe I·iphera l red c e l l radio iron inc orpora t ion a nd when  phl ebo­
tom i zed , the s e  dogs demonstra ted no obs erved pla sma e rythropo i e t in 
l evel cha nges . There fore , the sole  erythropo ietin pr oduc t i on site 
appea r s  to be the kidney in the dog ( Na ets , 1960; Mu irhe ad et a l . , 
1968 ) . Other nephre ctorni zed spec ies such a s  ra bb its ( Ers lev , 1 958 ) , 
ta ma r i n  ( Mira nd ,  1965 ) and rats ( Schooley a nd Ma hlma nn ,  1 972 ) exposed 
to hypox ia exh ib ited an  increa s ed pla sma erythropo i e tin t iters . Fried 
et�· ( 1969 ) found tha t Pephrectomy a lmost c ompl etely a bo l ished the 
erythropo i etic respon s e  of hypox i c  rats a nd ra bbits . Hypophys e ctomi zed 
rabbi ts d emonstrated sl ightly increased plasma erythr opoiet ic  a ctivity 
f o 11 owing hypoxia exposure (Ha 1 vors n, Roh a nd Fis her , 1 968 ) • 
Kura towska , Lewartowska and M i cha la k  ( 1961) provided evidence  
supporting the kidney as  the primary erythropoietin produc t i on site . 
They demonstrated increa sed erythropoietin  (ESF) t iters using isola ted 
rabbit  k idneys perfused with hypox ic blood. Also, F isher a nd Langstro 
(1967) per fused isola ted dog kidneys w i th a nemi c  bl ood a nd coba l t ,  
which enhanced erythropcietin-levels . 
K idney c ytol ogical erythropoi etin production sites have been 
l oca l i zed in  both the renoc ortica l  a nd renornedu l lary areas .  Soka be 
a nd Gro l lman ( 1 962)  have found tha t rena l c ortex remova l resu lted in a 
decreas�d per ipheral red c ell count whi l e  renal medu l la remova l 
demonstrated n o  cha nge . Mu irhead et a l .  ( 1 968 ) demonstrated grea ter 
c orti ca l  erythropo ietic  a ctivity tha n medu l la ry a ct iv i ty using anemic  
dog  extra cts. 
Osnes (19�8 ) f irst postula ted tha t erythropoiet ic st imu l a t ing 
fa ctor production was c ontroll ed by the juxtc.glomerul a r  a pparatus . He 
found tha t da i l y  bleed ing produced a decreased number and size of 
juxtaglomeru lar  c e l l  gra nules .  However , since this postu l a ti on 
several a uthors have d isputed a correlation between juxtag l omeru lar 
ce l l  granular ity a nd erythropo ietin plasma l eve ls (H irashima a nd 
Taka ku , 1962; Goldfarb and Tobia n, 1963). Donati et.§]._ . (1 968 ) 
repor ted that ren i n  and  erythropo ietin secret ion could  be disasso-
c iate d. · 
F is her , Ta yl or and Porteous ( 1965 )  u t i l i z ing  the ind irec t 
fluore s c en t  a ntibody techn i que , loca l ized erythropo i e t in in  sheep 
kiqney ' s g l omeru l a r  tu f t .  The j uxtag lomeru lar  c e lls , per i tubu l ar 
ca pi l lary  beds a n d  the capill a ry wa ll s of the l iver , lung a nd spl een  
d id not  dem onstra te f l uorescence .  Frenke l , Suk i a nd Bau m  (1 968 ) 
co rif irmed th is  f luorescenc e  in the peripheral port i on o f  the a nemi c  
s heep kidney g l omerul us . Busutt i l, Roh a nd Fi sher ( 1 97 1 )  demonstra te d 
intense per ipheral g l omeru la r-tu ft f luore s c ence  of anemi c  huma n a nd 
hypox i c  dog k i dneys . They suggested the g lornerular  e pi the l ia l  c e l s  
a s  the e rythropo ietin  s ou rce . Ant i -erythropoietin  incuba t ion with 
highly pur i f ied er ythropoiet in blocked  the gl omeru l a r  tu f t  f l u ore s ­
c ence . Thi s  ind ica ted tha t a non-spe c i f ic erythropo i e t in tra pp ing by 
the g l omeru l u s  i s  not l ike l y  i nvolved . 
Rena l Erythropoietic  Fa c tor 
Ren al erythropo ietin rec overy ha s been so va r ia bl e tha t  r e ­
s earchers ha ve searched for a non-erythropo ietica l ly a c ti ve fa c tor 
whi c h  g e nera tes  erythropo ietin  in vivo a n d  v itro systems . Contrera , 
Gord.on a nd We intraub  (1966 ) demonstra ted a n  a nemi c  mou s e  kidney 
erythr opo i e t ic fa ctor that stimu l a ted po l ycythem i c  mou s e  erythro­
po ie s i s  a fter incuba tion with norma l pla sma . They sepa ra ted th is  
hypox i c  mou s e  kidney fa c tor i n  the "l ight mitochondr ia l " fra c tion 
us ing a n  osmotic sucrose gradi ent and u l tra c entr i fuga t ion . 
Kura tows ka ( 1 968) reported erythropo�et ic  a ct ivi ty fo l l o wing incu­
ba t i on o f  a nemi c  rabbit kidney nuc lea r fra c ti on with e i ther an  
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a l pha -g l o bu l i n  or pla sma . She proposed  the k i dney produc es a n  
erythro po i et ic f actor which  c ombines with a pla sma al pha - g l obu l in 
formi r!g the erythropo i etica l l  y a ctive co mplex , erythropoi e tin . 
Gord on , Zanj a n i  a nd McLaur in (1971 )  proposed a s cheme f or 
erythropoi e t i n  bi ogenes i s  a nd a n  erythr opoietin negative f eedba c k  
jnflu ence o n  s ubstra te produc t i on.  They sug ges ted tha t hypox ia 
stimu lates the kidn ey to produc e  a rena l erythropoi e t i c  factor, 
11 erythr ogenin", wh ich a cts  on - a pla sma fa c tor , 11 erythropoi etinogen" . 
High pla s ma er ythropo i etin leve l s  are postula ted to a ct a s  a nega ti ve 
fe edba ck on erythropoi etinogen producti on . The pla sma erythropoietin 
a c ts ijpon an erythropoie t in respons ive c e l l  ca us ing differ entia tion  
in to pr oerythrobla sts . 
The da y-t o -da y kidney control of  erythropo ietin  produc t i on and 
feedbac k mechan i s ms i s  s til l not c ompl e te l y  unders tood ( F i sher , 1972 ) . 
Jac obson et a l . ( 1959 ) proposed that the ra t i o  o f  oxyg en supply to 
oxygen demand  or need proba bl y determines  the erythr opo i e t i c  response .  
Fisher (1969 ) propo sed r ena l c e l l oxygena ti on a s  the pr ima ry erythr o­
poietin produc t i on contro l  mecha n i sm .  Their hypo these s  sugge s ts the 
r ena l erythropoi et in  produ c t i on ra te i s  inverse l y  pr opor t i ona l to the 
cri t i  ca  1 rena l c e l l  oxygen conc entra tion . The oxygen s en s or mec hanis1n 
detec ts rena l c e l l oxygen cha ng es  and trigger s rena l erythropo ietic 
fa c tor produc tion . Rena l c e l l  eryt hrbg enin is  probabl y re l e a s ed to 
a c t on a pJ .a sma substra te to  genera te erythropo ietin . 
Severa l inves t iga tors have provided d irect e vid en c e  tha t rena l 
c e l l oxygena t i on c on tr o l s erythr opo iesis ( Rei s smann , 1950; Fi sher and  
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La ngston, 1967 ) . They demons tra ted that hypoxic b l ood per fu s ed i nto 
i s ola ted  k idneys stimu lates erythropo ietin production . A decreased. 
rena l c e l l  oxygen l eve l can  be produc ed by e ither decrea s ing the 
oxygen supply or increas ing the oxygen dema nd which  increa s �s the 
erythr opo i e t in produc t ion . 
Extra rena l �rythropoiet ic Fac tor 
Fri e d  (1972) ha s reporte? tha t hepa tectomy abol i s hed e xtraren a l  
erythropo ietin  produc ed i n  hypox ic , nephrec tom i zed  r ats a nd sugges ted 
the l i ver pla yed a ma j or extrarena l erythropo ietin produ c t i on r ol e . 
Trame z za n i ,  Merit� and Chiochio ( 1 971 ) reported tha t carotid  
body-a bl ated , phlebotomi zed ca ts fa iled to  increa s e  the ir reticul ocyte 
number s  and that anerrda a l so fo l lowed c arotid body r emova l .  They  
postu l ?ted the carotid body a s  a n  endocrine orga n s ecreting one  or 
more erythropo ieti c  c ontr o l l ing hormones . Pa u l o et g. ( 1973 ) sup­
port the hypothes i s  that the carot id body plays a n  i mportant role  in 
ra bbi t  erythropo i et i c  hypox ia res ponse . 
III. Phys iochemi ca l  Chara c ter i za t i on of  Erythropo i et in 
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Gordon et tl· ( 1 954) a nd Borsook et tl· (1954 ) ,  ear l iest  workers 
studying erythropo iet in's c hemica l compos ition,  found tha t erythro­
po i e ti ca l l y a c t ive pla sma wa s res i sta ht to bo i l ing . Slaunwhi te, 
Mirand a nd P renti c e  (1957) found tha t trypsin des troyed erythropoietin 
a nd sugge s ted tha t l ys ine or a rg i ni ne wa s conta ined in  the erythro­
po i et in pol ypept ide cha in .  
Ra mba ch , A lt and Cooper (1957) demonstra te .d tha t  erythr opo iet in 
migra tes  e le c trophoeretica l l y with a n  a l pha2 -gl obu l i n .  E s pa da a nd 
Gutn i sky (1970), using pure urine erythr opoietin ,  reported its 
el e c tr o phor etic  m obility to  be s l ightl y  l ess  than huma n s erum a l bumin . 
Thi s  pur i f ied human urinary erythropo ietin conta ined 65 percent pro ­
te in , 13 perc ent tota l hexos es , 8.9 pe rc ent he xo samine  and 7.5 perc ent 
s i a l i c  ac id . The a mino ac id c ompos ition wa s aspart i c  a c id ,  threon ine , 
ser ine , g luta mic ac id , pro l in�,  g l yc i ne,  a lan ine , va line , methi on ine , 
i s o l e uc ine , tyr o s ine , phenyl ala nine , h ist idine , lys ine  and arg i n ine . 
Goldwa s ser a n d  Kun g f 1971) reported the a pparent c ompiete 
erythropo i et in pur i f i c at ion from anemic  sheep pl a sma . The pur i fi ­
ca tion fa c tor wa s more tha n one mi l l ion . -E lectropho eret i ca l l y , they 
determin ed the molecular  we ight to be 45,800. They suggested the 
mol ecule wa s a s ingle pe ptide cha in c onta i ning a pprox ima te l y  30 per­
cent  c a rbohydra te and 70 percent prote in . The carbohydra te c on­
s ti tuents were ga l a c tose , ma nnose , g luc osa mine , g lu c o s e  a nd s ia lic 
a c id . Am ino  a c id micro-determina tion showe d no meth i on ine  or cys te i ne 
pres e nt a nd only a trac e  of  pral ine . The 30 per c e nt c a rbohydra te c on­
tent wa s 10.8 pe rcent  s ia l ic a c id. 
I V . Modes a nd S ites of  Action  of  Erythropo i et in 
Fri ed e t  .§1_. ( 1957) found tha t erythropo ietin  c a  u s ed immed ia te 
pre cursor c e l l  d i f ferent iat ion into recogniza b l e  a nd d if ferentia ted 
erythro id  c el l s .  Stahl ma n  (1964) s uggested erythropo i e tin's pr i mary 
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a c t i on i s  promoting ste rn c e l l  d i f ferentia t ion . He s tated tha t  the 
di fferent ia ted erythr o id c e l l  c ompartment i s  not s e l f-s us ta in ing and 
must be  supported by inf lux ing precursor c e l l s  from the c o mmi tte d stem 
c e l l  c ompartment . This  stem c el l  c o mpartment is s e l f-s u s ta in ing under 
norma l c ond i t i ons  but when there is an incr ea s ed red c e l l  dema nd thi s  
c ompa r tment i s  repopu l a ted by a plur ipotentia l c e l l.. Thi s  pluri­
potent ia l c e l l  c ompartment ca n d i fferentia te into myel o id, mega karyo ­
cyt i c  o r  erythroid e l ements . 
Bruc e  a nd McCu ll och ( 1 964 ) suggested the a lr eady  erythro id c om­
m i tted erythr opo i e tin sens i tive precursor c e l l . This erythropo ietin 
re spons ive c e l l i s  s epara te and  d ist inct  from a c o l ony-for ming stem 
c e l l . A l though the erythroid respons ive c e l l  is a lrea dy erythr oid 
c onmitte d, erythr opo iet in i s  s t i l l  require d to i n i t ia te hemog l obin 
synth8s i s . Stohlma n ( 1 964 ) ha s proposed tha t erythropo i etin  not  only 
initia te s , but a l s o govern s the hemog l ob in synthes is a nd c e l l m atur ­
a ti on ra te . Bottoml ey and  Smi thee (1 969 ) found tha t erythr opo i etin 
s t imu l a ted  ra bbi t bone marrow del ta -aminol evu l in i c  a c i d  s yntheta s e , 
the hemog l ob in rate  l imit ing en z yme . Erythropo ietin ' s c omp l e te bio­
c hemi ca l mecha n i s m  i s  not unders tood . However , F isher ( 1 972 ) sug ­
g e sted tha t i t  ma y de-repress a repre s sor whi c h  involves  gene  reduction  
or  indu c t i on . Thu s ,  erythropo ietin ini t ia te s  the ne ce s sary precurs or 
hemogl obin  RNA syn the s i s . The erythro id c e l is undergo d iv i s ions and 
ma ture a fter d i ffer en tiations . Some marrow c e l l s  d ie in  s it u  before  
emerg i n g  ( ine f fect i ve erythropo ies is ) , others ma ture without d iv id ing 
( the upper pa thwa y of s ki pped divis ions) and  ent er the peripheral 
blood a s  macrocytes ( Brecher a nd Stohlman , 1 959) . 
The pol yc ythem i c  mou se response to erythropo iet in i s  evidence 
for a stem c ell e f f ec t . Fi lmanowi c z  a nd Gurney ( 1 96 1 )  have shown 
that a sequent i a l erythropoietic  wave s weeps through the h�ma to­
po i etic t i s sue fol l owing erythr opo ietin inj ection .  Ea r ly erythro.id 
ce l l s  ( proerythrobla sts ) increa sed one day f o l lowing  erythropo ietin 
in jection a nd la te erythr o id c·e l l s  ( n .orrnobla sts ) increa sed.  dra-
ma tica  1 1  y on  the second da y. Bl ood reticul ocytes demon stra te d  no 
cha ng e  a fter one da y but increa sed a fter two da ys a nd r e ac hed a peak 
three  da ys a fter erythropo ietin adm in istra tion .  
Be s i de s  erythr opo ietin's pr imary stern ce l l e ffec t ,  evidence ha s 
been r eported showing erythropo ietin a f fects er·yt hr o i d  c el l  prol  i fer -
1J. 
a tion , ma tura tion a nd compartment rel ea s e. High s u s ta i ned erythro­
poietin  doses have been  reported to produce  a d irect  bon e  marrow 
reti cul ocyte r e l ea s e  from perfused i so lated rabbi t hind  l imbs ( F i sher 
and La jtha , 1 965) . Yo ffey et .§1_. ( 1 968 ) fou nd tha t the second day 
hypo �ic g u i n ea pig  demo nstra ted a s i gn i fi c a nt blood ret icu l oc yte  r i se 
a nd a s i gn i ficant  ma rrow reticu l oc yte decrea se , indica ti ng an a c ·­
c el era ted marrow r�ticuloc yte d i scharge dur ing ear l y  hypox ia . Stahlman 
et  �· ( 1 968 ) showed tha t norma l a n im al s  devel oped a r e t i cu l ocyte re -· 
spon s e  and  ma cro c ylosi s 24 hours earlier tha n hypertra n s fused  a nima ls 
a fter a sing l e , ma s s ive erythropo ietin dose .  Thei r  e xp l a na tion sug­
gested tha t  erythropo i et in had a n  effect on the a l rea dy di f ferentia ted 
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erythro i d  precurs ors . McCusky , Mei nike a nd Town send (1 972 ) suggested 
tha t eryt hropo iet in a l s o  infl uenced ·the splen i c  a nd bone marrow rni cr o­
en vironment , thereby esta blishing an  optima l e rythropo i e s i s  s i te .  
The s e  worker s  demons tra ted a n  e l eva ted bl o od fl ow a fter erythropo ietin 
a dm in i s tra t i on which  a c c ompan ied increa sed  erythropoi e s i s . 
V. Other  Fa ctors I nfl uenc ing Erythropo ie s i s  
Erythropo i e s  i s  a nd the Centra 1 Nervou s _S ystem 
Evi dence  of the centra l ner vous system ( CNS ) erythropo ie�i s  regu­
la t i on is  ba s ed on the  resu l ts obta ined wi th hypotha l a mi c  e l ectr ica l 
stimula t i on .  F i s her ( 1 972 )  reported work by Se ip  et tl. who demon ­
s tra ted that posterior hypothal arric el ec tri cal stimu la ti on wa s a c c om­
pan ied  by reticul ocyte a nd bl ood vol ume increa s e  in a b.out one-third of 
the stimu la ted ra bbits . Ra bbit hypotha lam ic sti n1ul a t i on produ ced 
increa s ed pla sma erythropoiet in level s �  Hypophysec tomy d i d  not a bo l is h  
the r i s e  i n  pla sma erythropoietin leve l s .  Ha l vorsen  ( 1 968 ) found tha t  
in 1 5  o f  2 6  ra bbi ts wi th posterior hypotha lm i c  l e s i on s , there wa s a 
reduced r et i cul ocyte res ponse to hypoxi�. Ta ka ku , Hira shima a nd 
Okina ka ( 1 96 1 ) reported tha t spla nchnic  nerve s e c t i on r educ e d  the 
hypoxic erythropo i et ic re sponse .  Atropine a bo l i shed the reticu l ocyte 
re spon s e  seen  fol l owing ra t and ra bbit hypotha l a mic  s timu l a t i on ( Paul a  
et .§1., 1 97 2 ) . A l so, atropine i nhibited incr ea sed ra bbit pl a s ma 
erythropo i etin  l eve l s  fo l l owing hypox i c  exposure . 
A large  nu mber of  chemica l a g ents have bee n  dem ons tra ted  to 
modi fy erythropoietin producti on exerting the ir  a c tion  by e ither i n­
crea s ing  or de crea s ing ki dney erythropo ietin produ c t i on . Some a c t by 
rena l mecha n isms that: (1 ) decrease  rena l bl ood f l ow ,  ( 2 )  i ncrea se 
rena l c e l l  oxygen  util ization and ( 3 )  interfere wi th k i dney oxygen 
uti l i za t i on ( F i sher , 1 97 2 ) . 
Coba l t  
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Coba l t  i s  a meta l known to stimu l ate erythropo i e s i s  (Goldwasser 
et &·, 1 957) . LaForet and Thoma s ( 1 956 ) found that c o ba l t  depres s ed 
marrow heme synthes i s  at  a c onc entra t i on which wa s l ower tha n tha t 
i nh i bi t ing oxygen  c onsumption . Goldwa s ser et a l. ( 1 958) reported 
that the crythropoi et i c  effec ts of cobal t  were reduced a fter bi la teral 
nephrectomy . F isher a nd La ng ston ( 1 967 ) suggested tha t c oba l t  ma y 
increa se erythropoi etin  production by a c ting a s  a n  e s s en t ia l me ta bo l ic 
enzyma ti c inhibi tor , thereby depr iv ing the cel l of  oxyg e n . F i sher 
et�· ( 1 96 6 )  demonstra ted tha t coba l t  decrea ses oxyge n  u t i l i za ti on in 
the i s ola ted perfu sed kidney by decrea s ing c e l l ul ar res pira tion  a nd 
the a c tivity or leve l  of  a fa ctor which  ina c t iva tes  erythropo ietin . 
End oc r·ine 
Endocrine  agents have be en studied extens ive ly  a nd it  a ppears tha t 
·AC TH,  a drenal ce>rti c ostero ids , thyro id s t imu la ting hormon e, thyro id 
hormone,  growth hormone , prola ctin and a ndrog en s enha n c e  erythropo ies i s 
by ( 1 )  increa s ing  cxygen uti l iza tion , ( 2) a cting through rena l mechan­
i sms a nd/or ( 3 ) directly  on  the ma rrow erythroid c el l s (Fi sher , Samuel s 
292553 . OUTH DAKOTA STATE UNIVERSITY LI RARY 
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and Langst on,  1 968; Fisher an d Cr ook, 1 962; Evan s ,  Rosenberg a nd 
Simps on,  1 961 ; Pesche l e  et _tl., 1 97 1 ; and Pe schele  et .§1., 1 971 ) . 
Hormones that inc re as e  renal cel l oxygen ut i li z at i on pr obabl y stimu­
l a te erythropo ietin  produc tion by cre at ing a r e l a t ive l y  criti c al r ena l 
sen s or c e ll oxygen def ic it . F i sher ( 1 972 ) states  that al tere d  hormone 
pr oduction ass oc i ated with al tered erythropoietin  production ma y be 
pol ycythem ia or an emia rela ted .  However ,  the ir physi o l og ica l da y-to­
da y s ig ni fi c an c e  in control l ing erythropoietin  pr oduc tion has n ot been 
esta bl ishe d.  
Cyc l i c  Nuc l e ot i des 
The hormone ef fect  upon target organs may s t imu la te membr a ne 
adenyl cyclase whi ch  increas es the intracellul ar c yc l ic ade nos ine-3', 
5'-�1onophospha te c oncentrat i on ( Butcher et .§1_., 1 965) . Cyc l ic 
a denos ine -3' , 5'-monophosphate ( cAMP ) ma y infl uence  membra ne perme ­
a bi l i ty a n d  s pec i f ic intracel lul ar enz yme activ i t i e s . Bottom l e y  
�!a l .  ( 1 971 ) reporte d. that cAJv1P s timu la ted  cu l ture d  ra bbit  marrow 
de l ta -amino  l evu l in ic  ac i d  syntheta s e  a c tivity . Cyc .l i c  A MP a n d  
erythropo ietin  ac ted  synerg istica l ly i n  thi s sys tem . Thi s  e f fect  wa s 
preven ted by protein synthes is inhibitors . Sc!loo ley  a n d  Mahlma nn 
( 1 97 1 ) demons tr ated tha t anti-erythropoietin  c ompl e te ly prevented the 
indu c ed cAMP erythropoiet ic stimula tion  in plethoric m i c e. A rel at i on­
ship between  erythr opoietin  pr oduction and rat k i dney cAft� cha nges  was 
reporte d fo l l owing cobal t inj ections (Rodgers , Ge orge  a nd Fis her , 1 972 ) . 
They  demon s tr a te d  incre as ed pl asma erythropoiet in l ev e l s  a f ter cobal t  
a dministra ti on . Thes e wor kers proposed tha t c oba
_
lt  s t imu la ted k idney 
a denyl cyc l ase increases cAfVlP, which tr iggers a kina s e  e n z yme to 
stimu l ate erythr ogenin  producti on . The produced erythr ogenin  then 
enha nc e s  pla sma erythropoieti n  ·genera ti on • 
. I nhibitors  o f  Erythropoi et i n  Production 
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Erythropo i etin  inhibitors  ca n be separa ted into ( 1) cheniic al 
a gents whic h inhibit  transport s ystems or enz ymes within the kidney a nd 
( 2) path ol og i c al inhibi tors which  ha ve been described in pla s ma or 
t i s su e  fra c t ions . A l s o:  pla s ma erythropoie s i s  inhibitors have been  
descr i be d  f o l l owing transfu s i on plethora a nd upon r eturning human sub­
jects to s e a  l evel a fter resid ing at high al t itud e s  ( F i sher , 1972) . 
E s trogens . 
High e strogen c oncentr ati ons admin i s tered to  young f e mal e s  pr o­
duce  severe a nemia  ( P i l i ero , Med i c i  a nd Ha ber , 1 968) . Jepson and 
Lowe nste in ( 1 966 ) s uggested tha t estrogens inhibit . the erythropo ietin 
e ffects  on the erythropoietin re spons ive stem c e l l but do  not af fec t 
la te �rarrow erythroid cel l ma tura tion . I t  a ppears  tha t h ig h  e s trogen 
doses  are c a pabl e of  depress ing erythropo ietin produc t i on whi l e  smal l 
d os e s  ma y d ire ctly  depres s  the bone ma rrow �espons ivene s s . 
VI . Meta bol i sm of Erythropo i etin  
Ro s s e  and Wal dmann ( 1 964 ) found that urine and s e rum erythropoie ­
t in l evels were proporti ona l whi ch suggested tha t t h e  hormone was 
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pla sma d er ived . They found tha t uri nary erythropoiet in was approxi ­
ma tel y  1 0  perc en t  of  the da il y  loss . Weintra ub  et al. (1 964) inj ec ted 
sheep  erythr opoietin  into dog s a nd found a 70 per cent pl asma erythro­
poi etin r edu c t i on dur ing the first 3 . 5 hours but were abl e  to r ec ov�r 
onl y  2-5 perc en t of  the urinary erythr opoi et in . They c a l cula ted the 
erythropo i etin r ena l c l eara nce between 0.1-0.6 ml per minute, 
whi ch repres ent ed on l y  a sma l l  fra ction of  the g l omer_·u l ar fil tra tion 
l'a te .  
Uri n e  alka l ini za tion by sod ium bicarbon ate infu s ion  s howed in­
creas ed ur ina ry erythropoietin c oncentra ti ons ( Ma rver a nd Gurney ,  
1968)., When they in fu sed ammon i um chl oride i nt o  thes e pa t i ents they 
fou nd a d oc �eass� u�inary crythropoietin cxcre+ton� ThesP au t�ors 
sug gested ":10n-ion i c  d i ffus ion"  as a pos s i bl e  erythropo i et in exc re­
t i on mechan i sm .  Thus , al ka l ine ur ine wa s pos tu l ated to c onta in  more 
ion i zed erythropo iet in with l es s  rena l tubular r ea bs orpt i on occurring. 
Jac obs on, D av i s  a nd A l pen (1 956 ) s uggested the l iver in  erythro­
poiet in met abol ism when they found higher pla sma erythropoi et in l evel s  
i n  anem i c  treated rabbits than anemi c control  ra bbits . Ma rked c entral 
l obu la r  degenera t i on of the ac etyl phenylhyd ra z in e  treated ra bbits  wa s 
observed and i t  was sugg ested tha t the l iver dama g e  had pr evented 
erythropo i e t in metabol ism .  
Burke  a nd Morse  ( 1 962) showed i n  i solated , erythropo i et in per ­
fu s ed ra t l ivers tha t erythropoietin l evel s  in  the l iver perfu sa tes 
from norma l ra ts  was s ignificantl y l ess  tha n  ra ts treated wi th ca rbon 
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tetra chlori de . The ir interpreta t i ons were tha t l iver dama ge  induced 
by CC14 resulted i n  de crea sed crythropo ietin meta bol ism . 
F i sher and  Roh ( 1 970) reported a ra pid erythr opo ietin  l os s  in  the 
iso l a ted perfu sed  dog l iver . Perfused dog livers  pre trea t ed with  
SKF -525A l , a drug  tha t inhibi ts he patic enzymes, prevented eryth:ro-
po ietin  ina c tiva t ion (Roh and Fi s her, 197 1 ). They interpreted their 
find ing s to mea n tha t an erythropoie tin e nzyma tic degra d at i on wa s 
oc curr i ng in the i s o la ted perfused l iver system . 
Reis sma n n  et al. ( 1 965) ca l cula ted the erythropo iet in d:i.s tr i -
butio n  s pa c e  to be twice the norma l ra t pla s ma volume . T hi s  ma y mea n 
tha t erythropoietin's fa st  i nitia l d isa ppeara nc e  c ompone nt i s  due to 
a l . ( 1 97 1 ) and Roh et .tl· ( 1 971) reported the norma l ra bbit pl a �m1a 
ha l f -li fe di s a ppeara nce  of  125I - l a bel l ed eryt hropo iet in .  The pl asma 
erythropoietin  d i s a ppea ra nce  curve showed a bipha s ic pa ttern , a n  early  
pha se w i th a mea n pla sma ha l f -time disappeara nce  of  36 minutes a nd a 
s l ow pha s e  w i th a mea n of  10 . 25 hours . 
VII. Feta l  Erythropo ies i s  
Ferr i ti n-Tra nsferr in Tra nsport Mechan i sm IrorJ. A bs orpt i on 
McCa nc e a nd Wi ddows on ( 1 93 7) introduc ed the c onc e pt that bod ily  need 
qua nt ita t ive l y  c ontrol s ir on absorpti on .  Ha hn et .§1· ( 1943 ) put  forth 
lsnii th ,  Kline and French Labora tories, Phi la delph ia , Pennsylva n ia , 
1 9101.  
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the muc osa l  bl ock  theory which  attr i butes.the ga str ointest ina l muc osa !  
c e l l s  c on trol  for ir on absorption . This t he or y  sta tes  t ha t  the in­
test ina l muc osa a bsorbs iron dur ing per iods of  need a nd r e je ct s  it 
when  store s  a r e  adequ ate . Iron taken into muc o sa l  c el l s  i s  converted 
into ferritin  a nd when the c elJ.s bec ome physiol og i ca l l y sa tur ated  with 
ferritin ,  further a bsorption is impeded unt i l  the iron is rel ea sed 
from ferr it in a nd tran sferred to the pla sma . C onra d et g. (1966) 
provided evidence t ha t ,  in the ra t,  the u l t ima te iron a bsorption 
regu l ator is the mu c osa ! bl ock the ory .  Underwood (1971) sta tes tha t  
A l l g ood a nd Brown demonstra ted the muc osa l  block  theory is n ot a ppl i ­
c a bl e to  ma n ,  the reby sta ting that  iron a bsorpt ion regu la ti on is 
spe c ies  ·s pe c if i c . 
Dav i s. , Luke a n d  Del ler (1966) found a n  iron -binding pr ote in 
(ga stroferr in ) in norma l  hu man ga str ic ju ic e . Norma l ga stroferr in 
l eve l s  inhibit exc e ssi ve iron a bso�ption and reduced l ev e ls permit 
enha n c ed a bsorption . 
Serum iron i s  derived fr om iron stored a s  ferr it in ( pro te in­
bound iron ) ( Fr ieden , 1973 and Underwood , 1971). Contr ol l ing  
ferr i t i n - ir on deta c hment fa ctors have bee n  demon stra ted by  Ma zure et  
21:_. (1958). T he ir studies proposed tha t  xa nthine ox ida se pr ov ide s 
a physi o l og i ca l deta c hment route . However , Frieden (1973 ) d isa greed  
a s  he showe d tha t  a vertebra te liver microsoma l fra c t ion conta ined a 
ferr itin r educta se system whi c h  deta che s the ferri t in - ir on c omplex. 
T hi s system requ ires NADH and FMN a s  e le ctron donor s .  A l so ,  
a l l opurinol , a x a nthine  ox ida se  inhibi tor, fa i l ed to a l ter iron de­
pos its or  mobi l i za t i on ( Ko zma , Sa lva dor a nd E l ion ,  1967 ) . 
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Apotra n s ferr in a n d  ferric iron intera ct  t o  form ferr i -tra n s f er r in, 
the iron transport form . Th e ferri-tra ns ferr in rea cts  with the 
erythroid  c e l l s ,  pl a c enta l tissue a nd othe-r t i s s u e s  for the forma tion 
of  e s sent ia l iron c ompounds . 
Tra ns fer a nd �a ke o f  Iron gy_ the Fetus 
One iron tra nsfer route is from ma terna l pla sma to  p l a c enta l 
tissue , then  to feta l pla sma . P l a c enta l  tran s ferr in tra n s f er is  many · 
t imes l e s s tha n iron tra ns fer . Therefore,  iron mu st d i sa s s oc ia te from 
tra n s ferr in on the ma ternal  s i de a nd then be tr an s ferred a cross  the 
pla centa l l.Ja rT i e:c and r· ea s s oc ia te w i 'Ll 1 f e ta l tra ns fer-r in m o l e cu l e s . 
Ba ker a nd Morgan ( 1 969 )  demonstra ted tha t pregna nt ra bbit  tra n s ­
ferr in i s  s pe c i f ica l l y  bound t o  feta l  pla centa . The feta l tra n s ferr in 
bin� i ng ca pa c ity increa sed markedly from the f i fte enth to the twenty­
e ighth g e s ta t i ona l day which para l l el s the sharp increa s e  in the iron 
tra n s fer ra te to the feta l pa rt in  advanc ing pregna ncy . Sw ine , ra ts 
a nd gu inea pigs demon stra te a s e c ond feta l iron transport route,  an 
embryotroph i c  rou te . King ( 1 972 ) sugges ted that the pa r ie ta l yol k  sac  
pla centa ma y represent  an  importa nt  ma terna 1 - fe ta 1 iron exchange  pa th­
way for a l l  s pec ies  dur ing la te gesta tion . 
Lark in , We intrau b  a nd Crosby ( 1 970 ) demons tra ted tha t  in  s ome 
respe c ts the iron tra nsport a cross  the ra bbit a l lantoi c  pla c enta a p ­
pea r s  a na l og ous  to the iron tra nsport a cross  the r e t i cu l oc yte men�brane . 
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Both the r e t i cu l ocyte and pla c enta ce l l ta ke u p  iron aga i n st a c on ­
centra t ion gra d ient , bind the tra ns ferr in - iron c ompl ex  t o  the c e l l 
membr a ne u t i l i z ing the iron and re l ea s ing the unsa tura ted tran s ferr in . 
They a l s o demonstra ted tha t l ittle  iron pa ss ing through the pla centa 
i s  incorpora ted into ferritin . 
D ibenzyl ine 
Phenoxyben zamine demonstra tes a l ong dura t i on o f  a c t i on ( 24 
hours ) . Agarwa l and  Harvey (1956) noted pr ol onged a c tion  due to 
s l ow rel ea se  from a receptor subs ta nce in the t i s su e . Goth (1970) 
a ttr i butes  this l ong a ct ion to be a s ta bl e  c ombina t i on betwe en the 
drug � nq the a l pha rec eptor . A l though c ompetiti on exists between 
the drug a nd ca techolam ines for the receptor dur i ng the ea r l y  s ta ges  
of  bl o c ka de , thi s  c ompetition become s ineffec tive as  the b l ocka de 
fu l l y deve l ops . 
Ca rd i ova scular  effects are var ied in normotens ive mamma l s . Some 
effects are  increa sed card ia c outpu t ,  decrea s ed tota l per iphera l re ­
s ista nc e , decrea sed mea n blood pressure a nd s ome pu pi l lary  c on ­
str ic t i on (G oth , 1970) . 
D i benzyl i ne is e ffective ly a dminis tered by a l l  r ou tes  a nd demon ­
stra tes h igh solubil ity a t  body pH with a ccumu l a t i on in  a d ipos e tis su e . 
Brod ie , Aronow , a nd Axelrod ( 1 959 ) observed dibenzyl ine meta bol ism by 
dea l kyla t ion to the corr e s pond i n g  amine , then excr et i on by the kid­
neys . 
.A tr opi ne 
Scha de , F e l sher a nd Conra d ( 1 969 ) demonstrated tha t a tropine 
i ncrea sed g� stro intestina l iron a bsorpti on . Atropine is a n  a c etyl ­
cho l ine c ompetitive a nta gonist  a t  smooth mus c l e ,  card ia c musc l e  and 
va r iou s g la ndula r  tis sue receptor s ites (Goth , 1 970 ) . The ga stro­
intest ina l e f f ec ts of  a tropine give r ise  to decrea sed mot i l ity a nd 
tone . 
Atropine  is we l l  a bsorbed thr ough the ga s trointes t ina l tra c t  and 
following subcuta neous injection . The meta bo l i sm is n ot c ompl ete ly 
known , a l though as  much as  50 percent of  a n  inj ec ted d ose  a ppears  
unc ha nged i n  the urine  with the rema inder a l s o  excreted in  the ur ine 
within  24 hours . Rabbits demonstra te a s erum a tropine es tera Be 
a c tivity (G oth, 1 970 ) . 
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MATERIAL S AND METHODS 
Exper imen ta l A n ima l s  
These inves t iga t i ons inc l�ded 5 6  Dutch-bel ted fema l e  ra bbits 
we ighing betNe en 1 700 and 2828 grams . A l l  ra bbi ts were in i t ia l l y 
examined t o  be n on - l e tha r g i c  a nd a pparently d i s ea s e  fr e e . Each  
a n ima l wa s c onta ined in ind ividua l sta inl e s s  s te e l  c a g e s  a nd pro ­
v i ded sa l t ,  wa ter a nd pe l l etj zed ra tion l ad  l ibitum . S i x  does  were 
n on -grav id , s ix d i ed fol lowing cardia c puncture , e i ght demon s tra t e d  
dead l i tters a nd f ive a borted be fore term ; there by 30 a n ima l s , f ive 
per grou p ,  were uti l i zed in these  exper iments . 
9e n e�9J. - P r o c ed�  
A n ima l s  were ada pted for severa l weeks to  the e xper imenta l en-
v ironm e n t.. A ta bl e o f  ra ndom numbers wa s used to s e pa ra te does  into 
c ontrol a nd experimenta l groups , ea ch  conta in ing f ive  a n ima l s .  Does 
were ma ted to Du tch ·- be l ted ma les  twice  on two c on se·c u t ive da ys . 
Pre -treatment blo od samples of a pprox ima te l y  1 2  m l  were ta ken 
via card i a c  puncture u s ing an 1 8  ga uge  needle  on da y 21  of g e s ta t ion 
u s i ng a sept i c  techn i ques  a nd s od ium hepar i n  a s  a n  a nti c oa gu l a n t . 
Doe trea tments were a dmin i s tered on da y 2i , day 24 a nd da y 27 
o f  g e s ta t i on a s  fo l l ows : 
Gro u p  I - sa l ine  controls  
Group II  - A tropine  
lR� bbi t  Chow , Ra l ston Purina Co o ,  S t . Lou i s , Missour i ,  63 188 . 
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Grou p  I I I  A tropine + Iron Dextra n 
Group  IV - D i ben zyl i n e  
Group V - D i ben zyl i n e + Iron Dextran 
Group  V I  - D i benzyl ine + Atropine + Iron Dextra n 
Trea tment o f  the d i f f e r e n t  groups were a s  fol l ows : 3 . 0 ml  
i soton i c  s a l i n e  wa s a dmin i s tered intra per i tonea l ly to  c ontr o l  a n i -
ma l s ; 1 33 . 0  mg/Kg a tropine2 in 95 perc ent EtOH wa s a dm i n i s tered sub-
c u ta neou s l y ;  50 . 0  mg/Kg iron dextra n3 in  i s oton i c  sa l ine  wa s a d�t i n­
i s tered intramuscularly ;  a nd 6 . 0  mg/Kg dibenzyl ine4 a nd i s oton i c  
sa l ine wa s a dm i n i sterE'.d intra per itonea l l y .  
Pos t-trea tment doe bl ood sampl e s  ( 1 2  ml ) were ta ken o n  da y 29 of 
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ge sta t i on pr i or t o  sa cr ific ing the doe . Anima l s  were s a c r i f ic ed by in-
duc ed ma s s i ve cardia c a ir embol ism .  The a bdom ina l ca v i ty wa s immed iatel y · 
o pe n e d  a nd fetu s e s  removed a nd pla c ed in a warmed , c ompartmenta l ized 
s ta in l e s s  s te e l  c onta i ner . 
Bl o od sampl e s  were obta ined from fetuses by s eve r ing the carotid 
a r tery a nd c o l l e c t ing the bl ood in g l a s s  test tube s c on ta in ing s od ium 
hepa r in . 
2DL -Hyos cyam in e  (A tr op i n e ) , K&K La bora tories , Inc . , P l a inv iew , 
N .  Y . , 1 3137 . 
3P i gde x Iron -Dextra n Inj ection , Agr icultura l D iv i s i on , Amer i c a n  
Cya namid Co . ,  Pr i n c e t o n , N.  J . , 0 8540 . 
4smi th , Kl ine a nd French La bora tori e s , Phi l a de l phia ,  P e n n s yl va n ia , 
1 9101 . 
Hemogram Determ ina tions  
Dup l i ca te white a nd red blood cel l s  were enumera ted uti l yz ing a 
Coul ter Counter Mode l F5 • Di lut i ons were prepa red w i th a Coul ter 
Counter Dua l -D i l uter6 u s ing I s oton7 a s  the di l uent a nd Za p-I s otonB a s  
a l ys ing a gent . Bl ood c el l counts were c orrec ted empl oying the 
Coul ter Counter Co inc idence Correction Cha rt9 . 
Dupl i c a te hemog l obin va lues were obta ined by the c ya nmethemo­
gl obin te c hn i que l O using Hyc eiR standard ( 6 . 0 ml ) l l  a nd a Bec kma n 
Grating Spec trophotometer Model  DB-G . 1 2  
Dupl i c a te hema tocr it va lues were determined empl oying the micro­
hema tocr it  techn i que . 1 3  
.....------
6cou l ter E l ectroni c s , Inc . , Hia l eah , Fl or ida , 330 1 1 .  
7coul ter E l ectron i c s ,  Inc . , Hia l eah , Fl orida , 330 1 1 .  
8cou l te:r E l ec tr on i c s , Inc . , Hia l ea h ,  Fl orida , 3301 1 . 
9cou l ter E l ec tronics , Inc . , Miami Springs , F l orida , 3301 1 .  
l Ocya nmethemog l obin Determina tions , Hyce l ,  Inc . , Hou ston ,  Texa s , 
77036 . 
1 1Hyc e l , In c . , Houston , Texa s ,  77036 . 
1 2Beckma n  Inst:ruments , Inc . , Fu l l erton , Ca l i forn ia , 92634 . 
1 3c l a y  Adams , Inc . , New York , New York , 10010 . 
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The Wintrobe indices  wer e determined from the fo l lowing for -
mu l a s :  
1 )  Mea n Corpuscular  Volume ( u3 ) = _ pa c ked c e l l vo l . x 1 0  
erythro c ytes , m i l l  i on/nun3 
25 
2 )  Mea n  C orpu s c u l a r  ( uug ) 
Hem og l obin ::: 
gm. hemog l ob i n/1 00 ml  bl ood x 1 0  
erytru·ocytes , m i l l  i on/mm3 
3 ) Mea n  Cor pu s c u l a r  Hemo­
g l obin c onc entra t i on 
(%) 
Hb . c oncentra t i on , gm/100 m l  
o f  bl ood x 1 0  
PCV 
A l l  d o e a nd fe tu s hemogram parameters wer e  c ompl eted within four 
hours after obta in ing bl ood sampl es. R e t i c u l o c yt e  smea r s  were pre-
pa red a t  th i s  t ime a c c ording to Brecher ' s  proc edure ( 1 949 ) .  On e 
t hou s a nd erythrocytes wer e counted u t i l i z i ng a n  oc u l a r  gr i d  a nd a n  
o i l  inm1er s i on l e n s . 
I ron Determinations 
Pre-trea tment a nd p o s t -tr ea tment doe bl o od samp l e s  wer e  a na l y zed 
i n d iv i du a l l y f or r ed bl ood c e l l iron a nd pla sma iron c ontent . Feta l 
bl ood wa s pool ed by l i tt er f or i r on d e te rm ina t i ons . Red blood c e l l s  
a nd p l a sma wer e s e pa ra ted a nd pre pa red for a na l ys i s a cc ord ing to  Wa de 
( 1 972 ) . Sampl e i r o n  · wa s  d e t ermined u t i l i z i ng a P erkin-E lmer A t om ic 
Abs orption  Spectr opho tometer , Model 303 . 1 4 S ta nda rd s  u t i l i zed for 
ir on d e t e rm ina ti o n s  were 1 ,  5 ,  10 ,  15 , 20 and 25 ppm . 
14Per k in -E lmer Corp . , tlorwa l k , Connec t i cu t , 06956 . 
26 
Data Ana lys i s  
Ana l ys i s  o f  da ta wa s compl eted by Dr . L e e  Tucker , Exper iment 
Sta t ion Sta ti s t i c ia n , and by us ing an Ol ivett i Underwood Prograrrm1a 
1 0 1 . 1 5  The a na l ys is  o f  var iance  wa s used a s  the t e s t  of  s ta t i s tica l 
s ign i f icance  for a l l  da ta . Red bl ood ce l l s , whi te bl ood c e l l s , pa c ked 
c e l l volume s , hemog l obin l evel s ,  reticul ocyte s ,  JvtCH , MCV , MCHC , red 
bl ood c e l l iron c ontent , pla sma iron content and body we ights were 
c ompa red for doe s . Feta l  comparisons were made for red  bl o od c el l s ,  
white bl ood  c el l s , pa cked cel l vo lumes , hemoglobin l eve l s ,  ret icu l o ­
cytes , JvlCH , MCV ,  MCHC , red bl ood cel l iron c ontent , pla sma iron c ontent 
and body we ights . 
Resu l ts o f  sta ti s t i ca l  computa ti ons are shown in  tables  1 , 2 ,  3 
and 4 .  
1 50l ivetti  Underwood , One Pa rk Avenue , New Yor k , New York , 1 00 1 6 . 
Ba s i s  Source  
Pre  We ight B/Gl 
B/A/G2 . 
Res idua l 
Post We ight B/G1 
B/A/G2 
Res idua l 
Pre Red Blood B/Gl 
Cel l s  B/A/G2 
Res idua l 
Post Red Bl ood B/Gl 
C e l l s  B/A/G2 
Res idua i. 
Pre White Bl ood B/G1 
Ce l l s  B/A/G2 
Res idua l 
P o s t  White Bl ood B/G 1 
C e l l s  B/A/G2 
Res idua l 
Pre Pa cked Cel l B/G1 
Volume B/A/G2 
Res idua l 
Ta ble 1 .  Doe Da ta Ana lys is  o f  Var i ance  
d . f .  Sum o f  
Squares  
5 0 . 6138 
24 3 .. 3 156 
30 3 . 92935 
5 0 . 3235 
23 2 .  7 1 19 
29 3 . 0350 
5 10 . 3408 
23 1 6 . 0690 
29 26 . 4098 
5 5 . 8677 
23 20 . 3334 
29 26 . 2010  
5 46 . 5251 
24 241 . 1 120 
·30 287 . 6370 
5 26 . 7710  
22 159 . 0698 
28 185 . 84 10 
5 96 . 9333 
24 492 . 2667 
30 589 . 2000 
Mea n 
Square 
0 . 1 13661 
0 . 1 6372 
0 . 2481 
0 . 1 320 
1 . 1483 
1 . 9722 
1 . 1 892 
L l390 
2 . 7938 
1 1 . 9850 
8 . 9814 
8 . 4470 
28 . 2967 
24 . 5500 
F Rat i o  
0 . 6942 ( NS )  
1 . 8797 ( NS )  
L 7540 ( NS )  
1 . 0440 (NS ) 
0 . 2331 ( NS )  
1 . 0632 ( NS )  . 
L 1 526 ( NS )  
I\) 
-.,J 
Table 1 .  Continued 
Ba s i s  Source  d . f .  Sum o f  Mea n  F Rat i o  
Squares Square 
Post Packed B/Gl 5 23 . 5 142 15 . 9448 0 . 5016  ( NS )  
Cel l Vol ume B/A/G2 23 707 . 5258 31 . 7870 
Residua l 29 731 . 1000 
Pre Hemog l obin B/G1 5 1 9 . 1 1 90 3 . 0280 0 . 98 1 2  ( NS )  
B/A/G2 24 54 . 9550 3 . 0860 
Res idua l 30 74 . 0740 
Post  Hemog l obin B/G1 5 2 . 3550 2 . 2094 0 . 7616  (NS ) 
B/A/G2 23 64 . 3747 2 . 90 10 
Res idua l 29 66 . 730 
Pre R e t icu - . B/(} 5 1 161 . 2333 317 .4700 0 . 9374 ( NS )  
l ocytes B/A/G2 24 6966 . 5667 338 . 6580 
Res idua l 30 8 127 . 8000 
Post Ret icu - B/G1 5 973 . 96 17 1327 . 3990 L 7134 ( NS )  
l ocytes B/A/G2 21 15295 . 4883 774 . 7360 
Res idua l 27 1 6269 . 4500 
Pre P la sma B/G1 5 4 . 9124 0 . 5843 0 . 8215 ( NS )  
hon B/A/G2 24 1 2 . 1586 0 .  7 1 13 
Res idua l 30 17 . 0710  
Post  P la sma B/G1 5 3 . 9246 4 . 1579 6 . 4767 ** 
Iron B/A/G2 22 10 . 1 967 0 . 6420 
Res idua l 28 14 . 1 210 
!\.) 
co 
Ba s is Source  
Pre  Red  Bl ood 




Post  Red Bl ood 
Cell  Iron 
B/G1 
B/A/G2 
Res idua l 
NSNot Sign ifica nt . 
lBetween Groupp . 
2Between Anima l s  Within Groups . 
** p < 0 . 01 .  







Ta ble 1 .  Continued 
Sum of 
Squares 
187 . 3374 
994 . 9267 
1 182 . 2640 
580 . 4174 
3423 . 4182 
4003 . 8350 
Mea n 
Square 
22 . 4608 
49 . 2610 
64 . 1 156 
181 . 9920 
F Ra tio  
0 . 4560 ( NS ) 
0 . 3523 ( NS ) 
I\) 
'° 
Tabl e 2 .  
Ba s i s Source  
Pre Mea n  B/G l 
Corpuscular  B/A/G 2 
Hemog l obin Tota l 
Post Mea n B/G l 
Corpuscular B/A/G 2 
Hemog l obin Tota l 
Pre Mea n B/G l 
Corpuscu lar B/A/G 2 
Volume Tota l 
Post Mea n  B/G l 
Corpuscular B/A/G 2 
Volume Tota l 
Pr(;? Mean  B/G l 
Corpuscular B/A/G 2 
Hemog l obin Tota l 
Concentra tion 
Post Mea n B/G l 
Corpu scular  B/P.jG 2 
Hemog l obin Tota l 
Concentra tion 
l Between Groups . 
2Between An ima l s  Within Groups . 
Doe Wintrobe Indices  Ana lys is o f  Va riance 



















Sum o f  
Squares 
78 . 0096 
25 1 . 17 14 
329 . 1810  
74 . 6247 
203 . 2262 
277 . 8509 
546 . 1785 
2085 . 497 1 
263 1 . 6756 
777 . 4364 
2270 . 7299 
3048 . 1663 
6 . 8992 
43 . 0615  
49 . 9607 
3 . 1 952 
53 . 5881 
56 . 7833 
NSNot S ignif icant . 
Mea n 
Square· 
1 5 . 60 19  
10 . 9204 
14 . 9249 
9 . 2375 
109 . 2357 
90 . 6737 
155 . 4872 
103 . 2149 
1 . 37 98 
1 . 7942 
0 . 6390 
2 . 4358 
F Rat i o  
1 . 4286 ( NS ) 
1 . 6 157 ( NS ) 
1 . 2047 (NS ) 
1 . 5064 ( NS )  
0 . 7691 (NS ) 
0 . 2624 ( NS ) 
w 
0 
Ta ble 3 .  
Ba s is Sourc e  d . f .  
Red Bl o od B/G1 5 
Ce l l s  D/G2 . 17 
F/D/G3 74 
Res idua l 97 
Whi te Bl ood B/G1 5 
Ce l l s  D/G2 17 
F/D/G3 74 
Res idua l 97 
Pa cked Ce l l  B/G1 5 
Vo lume D/G2 17 
. F/D/G3 74 
Residua l 97 
Hemog l obin B/G1 5 
D/G2 17 
F/D/G3 74 
Res idua l 97 
.Reticul ocytes B/G1 5 
D/G2 17 
F/D/G3 72 
Res idua l 95 
Fetus  Data Ana l ys is o f  Va r i a n c e  
Sum o f  
Squares 
8 . 76 15  
14 . 7452 
30 . 9264 
0 . 0802 
77 . 0775 
1 87 . 8542 
286 . 573 1 
0 . 3086 
1 67 . 8229 
2008 . 2902 
2709 . 9956 
17 . 0000 
10 . 4820 
156 . 3547 
1 92 . 1 890 
23 . 4200 
245624 . 226 
377825 . 217 
2J3565 . 993 
49456 . 000 
Mea n  
Squa r e 
1 . 7523 
0 . 8674 
0 . 4179 
0 . 0008 
1 5 . 41 55 
1 1 . 0502 
3 . 8726 
0 . 0032 
33 . 5646 
l l B . 1347 
36 . 6216 
0 . 1 252 
2 . 0964 
9 . 1 973 
2 . 597 1  
0 . 2414 
491 24 . 8452 
22224 . 9540 
2827 . 3050 
F Ra tio  
2 . 0202 ( NS )  
2 . 0754 * 
505 . 3494 ** 
1 . 3950 ( NS )  
2 . 8534 ** 
1217 . 41 90 ** 
0 . 2841 ( NS )  
3 . 2258 ** 
292 . 3714  ** 
0 . 2279 ( NS )  
3 .  541.3 *-*· 
10 . 7568 ** 
2 . 2103 . ( NS )  
7 . 8608 ** 
5 . 4310  ** 
w 
I-' 
Ba s is Source 
We ight B/G1 
D/G2 
F/D/G3 
Res idua l 
Red Bl ood B/G1 
Cell  Iron D/G2 
Residua l 
P l a sma Iron B/G1 
D/G2 
Res idua l 
NSNot S ignifica nt . 
* 
p < 0 . 05 . 
**p < o . o i .  
1Between Groups . 
2Does Within Groups . 











3Fetuses Within Does Within Groups . 
Ta bl e 3 .  Continued 
Sum o f  
Squares  
2255943 � 420 
4151 1746 . 405 
25997 178 . 974 
101 2 . 500 
4044 . 2130 
20165 . 7478 
24209 . 9520 
1 38 . 097 1  
539 . 3858 
677 . 4828 
Mea n 
Square  
451 188 . 684 
2441867 . 435 
337625 . 701  
10 . 1 25 
101 1 . 0532 
1 551 . 21 14 
34 . 5243 
41 . 4912  
F Ra t i o  
0 . 1848 ( NS )  
7 . 2325 ** 
33345 . 7482 ** 
0 . 9348 ( NS )  
0 . 5884 ( NS )  
w 
I\) 
Ba s i s 
Mea n  
Corpuscular  
Hemog lobin 
Mea n  
Corpu scular 




















1Between Groups . 
2Does W ithin Groups . 
** p < 0 . 01 .  
NSNot Significant . 
Tabl e 4 .  Feta l Wintrobe Indices  Ana l ys i s  o f  Var iance  










Sum o f  
Squares  
606 . 5538 
2841 . 1793 
3447 . 733 1 
16790 . 3580 
29587 . 1680 
36377 . 5260 
14 . 9787 
182 . 6353 
1 97 . 6140 
Mean 
Square 
121 . 3 107 
34 . 2310 
1358 . 07 1 6  
352 . 2281 
2 . 9957 
2 . 1742 
F Ra t i o  
3 . 5438 ** 
3.8556 ** 
1 . 3778 ( NS )  
w 
w 
RESULTS A ND D ISCUSS ION 
Ana l ys i s  of  var ia nce wa s empl oyed in testing trea tment e f fe cts . 
Doe a nd feta l results  are l i sted in ta bles 1 ,  2 ,  3 and 4 .  
I ndividua l doe hemogram va lues 1 cha n ged wi thin groups a l though the 
amount of cha nge wa s not s ign i f ica nt in a l l  parameters tes ted exc ept 
post pla sma iron . Group I I I  (Dibenzyl ine + Iron Dextra n )  demonstra ted 
a highly  s ign i f icant post pla sma iron increa se a nd group VI (D i-
benzyl ine + Atropine + Iron Dextra n )  demonstra ted s ign i f icantly  in-
creased post pla sma iron c onc entra tions . The l ac k  of s ign i f icance  
in  the rema in ing parameters  tested may be  a ttr ibuted to  ind ividua l 
doe va r�a bi l ity . 
The e f fec ts o f  dibenzyl ine incr�a s i ng pla sma iron i s  i n  a greement 
with Sc ha d e , Fel sher a nd Conrad ( 1 969 ) . D i benzyl ine by i ts a l pha -
a drenerg i c  bl ocka ge e f fec ts c ou l d  pos s ibl y be respon s ibl e for the 
in�rea sed iron a bsorption by the per iphera l ves s e l s .  
Control  a nd trea tment does demonstra ted decrea s ed hemogram 
va l u es l dur ing the l ast  tr imes ter of pregna ncy.  Guyton ( 1 97 1 ) sta tes 
tha t increa sed bl ood volume and iron deplet ion a re n orma l phys i c -
l og i pa l pregnancy changes . 
Group I I  (D ibenzyl ine ) and group I I I  (D ibenzyl i ne + I ron Dextra n )  
ha d h ighl y s ign i f i ca ntly decrea s ed l itier numbers .  Group IV ( A tro­
p ine) , group V (Atrop ine + Iron Dextran ) a nd group V I  ( D ibenzyl ine , 
1Ta bles of ind iv idua l doe hemogram va lues , a ppend ix : I ,  I I , 
I I I  a nd IV . 
A tropine a nd Iron Dextra n ) demonstra ted s igni f ica n t l y  decr ea sed l it ­
ter numbers .  The drug e f fe c ts a t  the d osa ges adm in i s tered a pparentl y 
a l tered optima l c ond i t i on s  for norma l pregna ncy . One gr oup I I  l itter 
exhibited tera togen ic  e f fe cts , �h i l e  severa l other group I I  l itters 
produ ced dead fetuses . 
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Ana l ys i s  of variance  demonstra ted no s igni f i ca nt cha ng e s  in feta l 
red  bl o od c e l l  ( RBC )  va l ue s , hemogl obin c oncentra ti ons , pa cked c e l l 
vo lume ( PCV) , red bl ood c e l l  iron content , pl a sma iron c on tent , feta l 
body we i ght a nd whi te bl ood cell  (WBC ) enumera tions . The l a c k  of  
s ig n i ficance  ma y be  der ived from the s ig n i f i ca nt var ia bi l i ty o f  the 
d oe s  with in ea ch  group a nd/ or the highly s ign i f icant  va r ia bi l i ty 
among the fetuses  within ea ch doe . 
F eta l trea tment mea n c orpus cu lar  hemog l obin ( MCH) a nd mea n  c or­
puscular  vo l ume ( MCV) va lues  demonstra ted s ign i ficantly  decrea s ed 
va lues  which  i s  c onsi stent with microcyt i c , hypochromi c  a n emia , a 
c ond ition not uncommon to newborn mamma l s .  The mea n c orpuscular  
hemog l obin  c oncentra t ion s ( MCHC ) demons tra ted no  s ign i f i ca nt a l ter -
a ti ons . 
Ind ividua l feta l hemogram va lues are l isted in  the a ppend ix , 
tabl es  X I  a nd X I I . 
The prepartum doe treatments with i ron d extra n ,  d ibenz yl ine  a nd 
a tropine fa i l ed to  e l i c it  a s ign i ficant erythropoiet i c  re sponse  nor 
d id the se c omb ina tions s ign if i ca ntly enha nce pla c enta l i r on tra nsport . 
Des p ite the ins ign i f i can ce of various  hemogram pa rameters , 
nota bl e  trends a r e  pres ent throughout the groups tested . See ta bl e s 
of means , pa ges  64 a nd 65 . The trea ted does a l l  demonstra ted in­
crea s ed mean post  pla sma iron l eve l s  with decrea sed red b l ood cel l 
iron l eve l s . Group  I I I  (Dibenzyl ine + Iron Dextra � )  demon stra ted a 
258 percent increa se in post pl a sma iron with corres ponding  decrea s·e s  
i n  hemogl obin l evel s ,  PCV and R BC  numbers . Th is  may ind i c a te tha t 
d iben zyl ine a nd iron dextran trea ted a n ima l s  transferred hemog l obin 
precurs ors to the fetuses . Group II (Dibenzyl ine ) trea ted does  · 
demonstra ted a 1 27 percent increa se  in  post plasma iron va lues  whi le  
the control  group pre trea tment va lues dropped 83 percent by  gesta ­
t iona l  da y 29 . Thi s  ma y ind i ca te tha t d ibenzyl ine  a l one i ncrea ses  
the mobi l i z a t i on of  ma terna l iron pos s ibly to  be tran s ferred to the 
feta l t i s sues . 
3 6  
Doe groups IV a nd V demonstra ted increa sed post  pla sma iron 
l eve l s , 1 17 percent a nd 120 percent , respect ive ly , whi c h  may ind ica te 
tha t a tr op ine increa ses  the iron mobi l izat ion within the tested a n i ­
ma l G . T h i s  increa s ed pla sma iron a l ong with norma l · decrea ses  in  RBC 
numbers ,  PCV , hemogl obin l eve l s  a nd red bl ood 
·
c e l l iron l evel s ma y 
ind icate  increa sed transport o f  erythropoiet i c  fa c tors to  the fetus . 
Group V (Atropine + Iron Dextran ) demonstra ted a 1 17 perc ent increa s e  
in WBC numbers whi l e  the other grou ps tested demon s tra ted decrea ses  i n  
WBC numbers . The WBC increa s e  ma y pos s ibly have a r i s en from the 
presence of murmn i f i ed fetuses  in  utero . 
Group V I  (D ibenzyl ine + A tropine + Iron Dextran ) doe post ­
trea tment MCH a nd f'/CV va lues  decrea sed , 95 percent a nd 96 perc ent , 
respec t ive l y ,  whi l e  the other groups demonstra ted a n  incr ea se in MCH 
a nd M.:V va l u e s . This ma y ind i cate that the chemica l s  a dministered 
a pparentl y a l tered the hemoglobin systems of the does tr ea te d . 
Feta l groups I I  a nd I I I  demonstra ted sma l ler c e l l s  ( fl'CV) a nd 
decrea sed amounts of  hemog l obin per ce l l  ( JVCH ) . However the pa cked 
cel l volume s wer e  a pproxima te l y  106 percent higher than control  
fetuses . A l s o ,  the RBC count and ret icul ocyte  numbers demonstra ted 
increases , 1 17 percent and 14� percent , respectively , when c ompared 
to the c ontrol fetuses . This may be indicat ive of enha nced pla c enta l 
tra nsport o f  erythropoietic  factors . 
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SUMMARY 
Thirty Dutch-bel ted fema l e  ra bbi ts and 99 feta.l hemogram para ­
meters were inve s t iga ted u ti l i z ing combina tions of  phenoxybenzamine , 
a tr opine and iron dextra n . Anima l s  were ra nd om l y  a s s igned .to c ontrol  
a �d trea tment groups . Group I (Control )  rec e ived 3 . 0  ml  0 . 87 percent 
NaC l , gr oup I I  r e c e ived 6 . 0  mg/kg dibenzyl ine , group I I I  received 
6 . 0  mg/kg d i ben zyl ine plus 50 . 0  mg/kg iron dextran , group IV  rece ived 
1 33 . 0  mg/kg a tr opine , gr oup V rece ived 133 . 0  a tr opine plus  50 . 0  mg/kg 
iron dextran a nd group V I  rece ived 6 . 0  mg/kg d ibenzyl ine  plus  1 33 . 0  
mg/kg a tr opine plu s 50 . 0  mg/kg iron dextra n .  D i benzyl ine wa s a d ­
m i n i stered intra per itonea l ly ,  a tr opine wa s inj ected subcuta neou s l y  
and iron dextra n wo. s a dm i n istered intramuscu larl y o n  g e sta t i ona l 
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da ys 21 , 24 a nd 27 . Pre -trea tment bl ood samples  were ta ken via card ia c  
puncture pr i or t o  trea tment admin istra tion a nd pos t-tr ea tment samples  
were ta ken  pr i or to  sa cr i fic ing on gesta t iona l da y 29 . Doe  para ­
meters eva l ua ted were red bl ood c el l  (ROC ) and wh i te b l ood c el l (WEC ) 
enumera.t ions , pa e ked cel l volumes ( PCV ) , hemoglobin  l eve l s ,  reticu l o ­
cyte s , Wintrobe indices , red bl ood cel l iron a nd pla sma iron con-
centra t i ons . 
Feta l sampl e s  investigated inc lud�d tota l body we ight ,  REC , WBC , 
PCV , hemog l obin l eve l s , reticul ocyte s ,  Wintrobe ind ic e s , red bl ood 
ce l l  i ron a nd pla sma iron conc entra tions . 
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•. 
Util i z ing the a na l ys i s  o f  va ria nc e , doe groups I I , I I I  a nd V I  
demonstrated s ig n i f ica nt increa ses  i n  post pla sma iron concentra tions . 
This  may i ndicate tha t d ibenzyl ine increa s e s  the s�rum i ron c oncen-
tra t i ons , pos s ibly  enhanc ing pla centa l tra nsfer to  the fetuses . The 
rema in ing doe parameters tested demonstra ted no  s igni f i ca nt sta t ist i -
ca l d i f ference s .  
Diben zyl ine  trea ted fetuses  demonstra ted s i gn ifica ntly  decrea sed 
mean c orpu scu lar  hemog l obin and mea n corpu scu lar  vo l ume s ;  however , 
these trea tment groups demonstra ted perc entage increa s e s  in  RBC 
numbers ,  PCV a nd hemog lobin  l evels . The occurre n·c e of rn i crocytic  a nd 
hypochromic  red bl ood cel l s  i s  not unusua l in newborn a nima l s . The 
rema i n ing feta l  parameter s demonstra ted no s ign i f ica n t  c ha nges . which 
ma y poss ibly  indi cate no synerg istic  erythropoi etic  i nterre la t i on-
ships  between trea tments . The preparturn trea tments o f  d ibenzyl ine , 
a tropine  a nd iron dextran fa i l ed to sta t i stica l ly demonstra te enhanced 
pla centa l  iron tran sport by the methods and n� ter ia l s  u sed in  these 
experiments . 
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RAW DATA TABLE I 
PRE -TREATJViENT SAMPLES 
An ima l We ight RBCl WBC2 PCV3 Hb4 Reticu l e -
gm % g% cytes5 
Group I (Contr o l ) 
1 21 60 5 . 61 3 . 68 38 . 0  1 3 . 8  2 . 0  
2 2250 3 . 96 2 . 83 39 . 0  1 2 . 4  3 . 3  
3 21 50 5 ,. 39 6 . 42 40 . 0  1 2 . 9  3 . 5 
4 2614 4 . 64 5 . 77 36 . 0  12 . 5  . 3 . 2  
5 2280 5 . 84 7 . 36 42 . 0  1 2 . 8  2 . 5  
Mea n 2291 5 . 09 5 . 21 39 . 0  1 2 . 9 2 . 9  
Group  I I  (D i benzyl ine ) 
1 2070 6 . 76 1 1 . 86 43 . 0  1 3 . 1  1 . 9  
2 1770 6 . 31 6 . 76 42 . 0  1 3 . 2  4 . 0  
3 1 960 5 . 97 5 . 64 43 . 0  1 4 . 7  5 . 1  
4 2420 6 . 24 8 . 29 41 . 0  1 3 . 0  3 . 4 
5 2058  5 . 84 3 . 28 37 . 0  1 1 . 8  5 . 7 
Mea n  2056 6 . 22 7 . 1 7 41 . 2  1 3 . 2  4 . 0  
Group I I I  ( D i ben zyl ine + Fe ) 
1 260 0  5 . 86 6 . 66 36 . 0  1 1 . 6  L l  
2 2394 3 . 53 2 . 56 28 . 0  8 . 8  5 . 2  
3 1 930 5 . 67 6 . 92 39 . 0  1 2 . 4  4 . 8  
4 201 0  6 . 01 7 . 74 40 . 0  1 2 .  7 5 . 9  
5 2280 7 . 92 42 . 0  14 . 0  2 . 4  
Mea n 2243 5 . 27 6 . 36 37 . 0  1 1 . 9  3 . 9  
Group IV ( A tropine ) 
l 2692 4 . 54 4 . 76 34 . 0  1 1 . 4  4 . 4  
2 2828 4 . 82 7 . 26 36 . 0  1 2 . 4  3 . 1  
3 2080 4 . 51 1 . 48 42 . 0  1 3 . 3  2 . 1 
4 1 7 1 0  6 . 84 8 . 17 44 . 5  1 3 . 9  1 . 1  
5 2 1 1 0  5 . 56 9 . 67 40 � 0  1 2 . 7  2 . 4  
Mea n  2284 5 . 67 4 1 . 3 1 2 . 7  2 . 6  
Group V ( A trop ine + Fe ) 
1 2162 5 . 88 6 . 40 38 . 0  1 3 . 7 3 . 4  
2 2250 4 . 78 7 . 46 40 . 0  1 3 . 2  3 . 0  
3 21 60 5 . 82 6 . 46 40 . 0  1 2 . 5  1 . 8 
4 21 10  6 . 07 6 . 50 45 . 0  1 3 . 5  2 . 0  
5 2330 5 . 64 4 . 55 38 . 0  1 4 . 8 3 . 7 
Mea n 2202 5 . 64 6 . 27 40 . 2  1 3 . 5  2 . 8  
RAW DATA TABLE I .  Continued 
Anima l We ight 
gm 







1 878 6 . 82 9 . 46 
· 2330 5 . 66 5 . 33 
2250 5 . 36 7 . 33 
1700 6 . 10 7 . 64 
2230 5 . 96 3 . 52 
2078 5 . 98 6 . 66 
1Red Blood Cel l .s  x 106/mm3 • 
2Wh ite Blood Ce l l s  x io3/mm3 • 
3Pa c ked Cel l Volume . 
4Hemog l obin Conc entration . 
5Ret icul ocytes/100 erythrocytes . 
Pcv3 
% 
43 . 0  
44 . 0  
38 . 0  
43 . 0  
41 . 0  
41 . 8 
1 3 . 7 
10 . 3  
1 2 . 5 
13 . 5  
1 0 . 6  




3 . 4  
4 . 8  
2 '.' 8  
2 . 0  
3 . 4  
3 . 3 
51  
RAW DATA TABLE I I  
PRE -TREATMENT SAMPLES 
Anima l REC Plasma tveHl MCV2 JvCHC3 
F e  Fe 
mg% mg% uug u3 % 
Group I ( Control ) 
1 53 . 78 2 . 38 24 . 60 67 . 74 36 . 32 
2 46 . 86 2 . 26 31 . 48 98 . 62 31 . 92 
3 46 . 79 1 . 1 2 23 . 93 74 . 21 32 . 25 
4 4 1 . 51 3 . 1 2 26 . 91 78 . 59 34 . 24 
5 59 . 96 1 . 33 21 . 90 7 1 . 86 30 . 48 
Mea n 49 . 78 2 . 04 25 . 76 78 . 10 33 . 04 
Group I I  (Dibenzyl ine ) 
1 46 . 98 1 . 36 1 9 . 36 63 . 56 30 . 47 
2 56 . 64 1 . 61 21 . 00 66 . 56 31 . 54 
3 50 . 37 1 . 89 24 . 62 72 . 03 34 . 1 8 
4 . 44 . 74 1 . 29 20 . 85 65 . 76 31 . 70 
� 51 . 38 1 . 73 20 . 22 63 . 4 1 3i . 89 
Mean  50 . 02 1 . 58 21 . 21 66 . 26 31 . 96 
Group I I I  ( D i ben zyl ine + Fe ) 
1 53 . 41 1 . 21 1 8 . 94 61 . 38 30 . 83 
2 49 . 35 1 . 10 25 . 07 78 . 88 31 . 61 
3 5 1 . 02 1 . 21 21 . 88 68 . 80 3 1 . 79 
4 48 . 34 1 . 68 21 . 13 67 . 39 30 . 37 
5 57 . 47 1 . 30 33 . 33 
Mea n  5 1 . 92 1 . 30 21 . 76 69 . 1 1 3 1 . 59 
Group IV (Atropine ) 
1 49 . 72 2 . 51 25 . 25 7 4 . 98 33 . 68 
2 45 . 20 1 . 57 27 . 89 83 . 83 33 . 48 
3 48 . 7 1 1 . 61 29 . 49 93 . 1 3 31 . 67 
4 5 1 . 61 1 . 1 5 20 . 31 65 . 01 3 1 . 24 
5 49 . 26 0 . 89 22 . 82 7 1 . 88 31 . 75  
Mea n  48 . 90 1 . 55 25 . 15 77 . 77 32 . 36 
Group V (Atropine + Fe ) 
1 61 . 81 1 . 48 20 . 36 63 . 39 32 . 10 
2 5 1 . 20 1 . 68 27 . 83 83 . 69 33 . 25 
3 44 . 74 1 . 22 22 . 51 68 . 73 32 . 75 
4 49 . 91 2 . 90 23 . 72 74 . 14 32 . 00 
5 50 . 09 0 . 91 22 . 14 67 . 32 32 . 89 
Mean  51 . 55 1 . 64 23 . 31 7 1 . 45 32 . 60 










F e  
mg% 
P l a sma 
F e  
mg% 
V I  (D ibenzyl ine + A tropine + 
41 . 42 1 . 48 
52 . 58 1 . 68 
48 . 80 1 . 22 
50 . 28 2 . 90 
47 . 05 0 . 91 
48 . 03 1 . 64 
1 Mea n Corpuscu l ar Hemog lobin . 
2Mea n  C orpuscular  Volume . 
Fe ) 
uug 
20 . 07 
20 . 34 
23 . 32 
22 . 1 2 
30 . 71 
23 . 3 1 
3Mea n  Corpuscular Hemoglobin Concentra tion . 
6 3 . 00 
6 6 . 26 
70 . 90 
70 . 44 
93 . 37 




31 . 85 
30 . 70 
32. 90 
31 .40 
32 . 89 
31 . 95 
53 
RAW DATA TABLE I I I  
POST-TREATMENT SAMPLES 
An ima l We ight  RBCl WBC2 PCV3 Hb4 Reticu l o -gm % g% cyte s5 
Group I ( Cor)tr ol ) 
1 2 100 4 . 60 4 . 92 38 . 0  1 2 . 1 3 . 0  
2 2300 3 . 48 5 . 60 40 . 0  1 2 . 0  1 . 2  
3 2230 4 . 14 1 . 64 32 . 0  1 1 . 2  1 . 1  
4 2647 4 . 28 3 . 76 30 . 0  9 . 8  . 0 . 8  
5 2410  5 . 34 5 . 86 41 . 0  1 2 . 6 1 . 8 
Mea n  2337 4 . 37 4 . 36 36 . 2  1 1 . 5  1 . 6  
Group I I  ( D i benzyl ine ) 
1 1890 6 . 45 9 . 37 42 . 0  1 3 . 0  2 . 6  
2 1730 5 . 74 6 .. 45 39 . 0  1 2 . 3 2 . 8  
3 2070 4 . 36 5 . 64 34 . 0  1 1 . 0  5 . 8 
4 2290 4 . 68 3 . 52 33 . 0  10 . 3  2 . 8  
5 2050 4 . 60 2 . 24 33 . 0  10 . 2  6 . 7 
Mea n 2006 5 . 1 7 5 . 44 36 . 2  1 1 . 4  4 . 1 
Group I I I  ( D i benzyl ine + Iro�) 
1 2470 4 . 03 2 . 28 34 . 0  10 . 4  3 . 8  
2 2240 3 . 56 7 . 48 28 . 0  8 . 8  5 . 5  
3 2070 5 . 20 7 . 08 40 . 0  1 2 . 5 3 . 0 
4 1 920 5 . 03 7 . 54 36 . 0  1 0 . 6  7 . 6  
5 2220 5 . 1 3 5 . 40 39 . 0  . 12 . 5 5 . 0  
Mea n  2184 4 . 59 5 . 96 35 . 4  1 1 . 0  5 . 0 
Gr oup IV (Atropin e ) 
1 2410 4 . 32 6 . 69 34 . 0  1 0 . 4  2 . 8  
2 2680 4 . 82 3 . 98 38 . 0  1 2 . 0  5 . 4  
3 2140 4 . 51 3 . 7 6 38 . 0  1 1 . 3  1 . 6 
4 1 596 6 . 84 6 . 24 41 . 0  1 3 . 0  4 . 4  
5 1 900 5 . 56 4 . 25 34 . 0  1 1 . 2  3 . 2  
Mea n 2145 5 . 21 4 . 98 37 . 0  1 1 . 5  3 . 5  
Group V ( A trop ine  + Iron ) 
1 21 10 4 . 20 7 . 93 35 . 5  1 1 . 0  2 . 1  
2 2350 4 . 42 5 . 40 35 . 0  1 1 . 9 2 . 0  
3 2080 4 . 86 41 . 0  1 3 . 0  1 2 . 0  
4 1 870 5 . 80 7 . 63 41 . 0  1 3 . 0  2 . 8 
5 2230 5 . 44 7 . 04 43 . 0  1 1 . 5  3 . 7 
Mean 21 28 4 . 94 7 . 00 39 . 1  1 2 . 1  4 . 6  
RAW DATA TABLE I II .  
An i ma l  Weight RBC;l WBC2 
gm 
Group V (A tropine + Atropine + Iron ) 
1 1770 5 . 78 8 . 34 
2 i 960 5 . 20 5 . 33 
3 2080 4 . 1 5 4 . 64 
4 1560 5 . 55 10 . 28 
5 no  da ta 
Mea n 1842 5 . 17 - 7 . 15 
1Red Bl ood Ce l l s  x io6/mm3 . 
2whi te Bl ood Cel l s  x io3/mm3 • 
3ra cked Ce l l  Vo lume . 
4
Hemog lobin  Concen tra t ion . 
5




37 . 5  
38 . 0  
32 . 0  
38 . 0  
36 . 4  
Hb4 
g% 
1 1 . 6 
8 . 8  
10 . 4  
1 1 . 8  
- 10 . 65 
54 
Ret icu l o­
cytes5 
3 . 6  
5 . 2  
3 . 8  
3 . 7  
55 
RAW DATA TABLE IV 
POST -TREATMENT SAMPLES 
An ima l RBC Pla sma MCHl rvcv2 M:HC3 
Fe  Fe 
mg% mg.% uug u3 % 
Group I (Control ) 
1 48 . 7 1  1 . 79 26 . 20 82 . 61 31 . 71 
2 43 . 54 1 . 20 34 . 64 1 14 . 98 30 . 12 
3 58 . 67 1 . 34 26 . 90 77 . 20 34 . 84 
4 37 . 55 2 . 55 22 . 75 70 . 0 1  32 . 02 
5 49 . 14 1 . 62 23 . 52 76 . 86 30 . 61 
Mea n  47 . 52 1 . 70 26 . 82 84 . 33 31 . 86 
Group I I  ( D i ben zyl ine ) 
1 45 . 57 1 . 10 20 . 15 65 . 1 2 30 . 95 
2 48 . 06 1 . 93 21 . 42 67 . 94 31 . 54 
3 57 . 66 1 . 72 25 . 23 77 . 98 32 . 35 
4 1 0 . 79 2 . 33 23 . 35 70 . 5 1 32 . 21  
5 44 . 82 2 . 94 22 . 28 7 1 . 74 3 1. 06 
Mea n  41 . 38 2 . 00 22 . 49 70 . 66 31 . 62 
Group I I I  ( Dibenzyl ine + I ron ) 
1 52 . 58 4 . 1 2 25 . 82 84 . 40 30 . 59 
2 36 . 35 2 . 26 24 . 68 78 . 54 3 1  .. 43 
3 47 . 88 2 . 37 24 . 06 77 . 00 31 . 25 
4 42 . 71 3 . 94 21 . 08 " 7 1 . 58 29 . 44 
5 47 . 97 4 . 1 3 24 . 37 7 6 . 02 32 . 05 
Mea n 45 . 50 3 . 36 24 . 00 77 . 51 30 . 95 
Group IV ( A tro pine ) 
1 47 . 23 1 . 46 24 . 05 7 8 . 62 30 . 59 
2 43 . 82 1 . 94 26 . 49 82 . 78 32 . 00 
3 47 . 88 1 .  77 3 1 . 18 1 03 . 44 30 . 14 
4 6L 35 2 . 01 22 . 38 70 . 58 31 . 70 
5 40 . 50 1 . 51  25 . 23 76 . 58 32 . 94 
Mea n 48 . 1 6 1 . 74 25 . 87 82 . 44 31 . 47 
Group V (Atropine + Iron ) 
1 44 . 10 1 .  73 26 . 1 6 84 . 42 31 . 04 
2 47 . 60 1 . 63 26 . 90 7 9 . 1 0 34 . 00 
3 47 . 14 2 . 55 26 . 62 84 . 28 31 . 58 
4 50 . 92 1 . 95 22 . 42 70 . 69 31 . 70 
5 53 . 04 2 . 06 21 . 1 4 79 . 04 26 . 74 
Mea n  48 . 56 1 . 98 24 . 65 79 . 51 31 . 01 
56 
RAW DATA TABLE IV . Continued 
An ima l RBC Pla sma MCH1 Mcv2 MCHC3 
Fe Fe 
mg% mg% uug u3 % 
Group V I  ( D ibe nzyl ine + Atropine + Iron ) 
l 46 . 49 2 . 35 20 . 00 64 . 94 30 . 80 
2 
3 43 . 27 3 . 26 25 . 06 77 . 10 32 . 50 
4 45 . 66 3 . Q2 21 . 26 67 . 57 31 . 47 
5 
Mea n  45 . 1 4 2 . 88 22 . 1 1 69 . 87 31 . 59 
1Mea n  Corpuscu l a r  Hemog l obin . 
2Mea n Corpuscular  Volume . 
3Mea n Corpuscu lar  Hemogl obin Concentra tion . 
RAW DATA TABLE V 
GROUP I ( CONTROL ) FETUS SAMPLES 
F e tus RBC1 woc2 PCV3 Hb4 R e t i c u l o - RBC P l a sma MCH6 MCV7 MCHC8 TBW9 
% g% c yte s5 F e  Fe 
mg% mg% uug u3 % gm 
Doe 1 
1 3 . 14 2 . 18 51 . 0  13 . 6  1 . 6 87 . 13 10 . 22 43 . 25 1 62 . 20 26 . 67 37 . 76 
2 2 . 50 2 . 24 46 . 0  1 2 . 0  - - - 48 . 00 184 . 00 26 . 09 36 . 32 
3 2 . 64 1 . 1 9 48 . 0  1 2 . 4  4 . 4  46 . 98 18 1 . 84 25 . 83 30 . 44 
4 3 . 22 1 . 22 47 . 0  1 2 . 7  5 . 6  39 . 46 146 . 01 27 . 02 41 . 69 
5 4 . 06 2 . 57 56 . 0  14 . 2  5 . 2  35 . 02 1 38 . 10 25 . 36 42 . 1 8 
Doe 2 
1 3 .20 1 . 29 44 . 0  14 . 4  7 . 2  56 . 91 1 . 48 44 . 92 1 37 . 29 32 . 72 3 1 . 80 
2 2 . 60 7 . 00 . 49 . 0  1 1 . 4  1 1 . 6  43 . 58 1 88 . 10 23 . 16 27 . 1 2 
3 3 . 06 8 . 20 42 . 0  1 1 . 1  7 . 1  36 . 22 137 . 03 26 . 43 26 . 1 9 
4 2 . 76 8 . 86 44 . 0  1 1 . 6  17 . 4  42 . 1 3 1 59 . 13 26 . 48 27 . 23 
5 3 . 82 8 . 81 48 . 0  1 2 . 8  10 . 0  33 . 46 125 . 49 26 . 67 28 . 61 
6 3 . 10 6 . 84 53 . 0  1 1 . 9  18 . 7 38 . 38 170 . 98 22 . 46 28 . 05 
7 2 . 94 4 . 43 48 . 0  1 2 . 4  13 . 8  42 . 26 1 63 . 54 25 . 84 30 . 96 
8 2 . 92 4 . 32 47 . 0  12 . 0  1 3 . 6  41 . 03 1 60 . 68 25 • . 53 22 . 62 
9 2 . 74 2 . 25 47 . 0  10 . 9  · 14 . s 39 . 7 1 . 171 . 22 23 . 1 9 25 . 03 
Doe 3 
1 3 . 38 1 . 64 48 . 5  13 . 2  1 2 . 8  63 . 04 1 . 37 38 . 99 143 . 29 · 27 . 24 3 6 . 52 
2 3 . 18 1 . 78 50 . 0  14 . 2  12 . 2  44 . 65 1 57 . 23 28 . 40 24 . 01 
3 2 . 1 5 1 . 32 40 . 0  9 . 8  s . o  45 . 35 1 86 . 05 24 . 38 27 . 30 
4 2 .  72 1 . 92 46 . 5  1 1 . 6  1 9 . 0  42 . 65 170 . 96 24 . 95 36 . 1 0  
5 3 . 65 2 . 51 55 . 0  13 . 6  20 . 4  37 . 1 2 1 50 .  68 . 24 . 64 31 . 64 
6 3 . 42 1 . 34 53 . 0  1 2 . 9 1 6 . 9  37 . 72 1 54 . 97 24 . 34 3 1. 84 
()1 
-l 
RAW DATA TABLE y .  Continued 
-
RBC1 WBC2 Pcv3 Hb4 MCH6 
'7 
MCHC8 TBW9 Fetus Reticu lg - RBC . P l a sma MCV ' % g% cytes Fe Fe 
mg% mg% uug u3 % gm 
Doe 3 
7 3 . 14 1 . 38 54 . 0  1 3 . 0  15 . 8  41 . 46 172 0 24 24 . 08 38 . 56 
8 2 . 66 1 . 28 45 . 0  1 1 . 6  20 . 4  43 . 61 1 69 . 17 25 . 78 36 . 21  
9 3 . 41 6 . 02 54 . �  1 3 . 1  1 9 . 6  38 . 42 1 59 . 82 24 . 04 35 . 48 
10 3 . 14 1 . 69 46 . 0  1 1 . 2  1 6 . 4  35 . 83 146 . 50 24 . 46 38 . 15 
Doe 4 
1 3 . 60 4 . 22 50 . 0  1 3 . 5  7 . 0  86 . 10 6 . 36 37 . 46 136 . 68 27 . 02 37 . 28 
2 3 . 37 2 . 36 49 . 5  1 2 . 9 4 . 2  38 . 28 146 . -SS 26 . 08 35 . 43 
3 3 . 70 3 . 37 53 . 0  1 4 . 8  8 . 0  42 . 66 143 . 06 29 . 82 41 . 83 
4 2 . 94 3 . 66 48 . 0  1 2 . 8  43 . 78 1 163 . 54 26 . 77 44 . 73 
5 3 . 12  2 . 7 1 48 . 0  1 3 . 1  7 . 8  41 . 99 1 53 . 85 27 . 30 43 . 26 
6 2 . 32 1 . 94 44 . 0  1 2 . 0  6 . 8  5 1 . 72 1 89 . 66 27 . 27 32 . 50 
7 1 .  70 2 . 92 46 . 0  14 . 0  1 1 . 8 82 . 32 27 1 . 39 30 . 25 36 . 93 
8 2 . 36 3 . 44 48 . 5  1 5 . 4  15 . 4  57 . 99 205 . 96 38 . 13 43 . 55 
Doe 5 
1 2 . 58 4 . 56 51. . 0  1 3 . 0  1 9 . 4  62 . 27 3 . 59 37 . 46 1 38 . 68 27 . 02 40 . 43 
2 3 . 74 0 • . 94 54 . 0  1 3 . 8  21 . 5  38 . 28 146 . 88 26 . 08 3 1 . 89 
3 3 . 78 1 . 58 54 . 0  1 3 . 9  23 . 5  42 . 66 143 . 06 29 . 82 42 . 72 
4 3 . 46 2 . 68 60 . 0  1 4 . 8  16 . 8  43 . 78 1 63 . 54 26 . 77 35 . 30 
5 3 . 54 1 . 42 53 . 0  1 3 . 8  1 8 . 4  41 . 99 1 53 . 85 27 . 30 39 . 91 
6 3 . 68 1 . 06 54 . 0  1 3 . 9  17 . 8  5 1 . 72 1 89 . 66 27 . 27 43 . 20 
. 7 3 . 20 1 . 1 2 55 . 0  14 . 6  17 . 4  82 . 32 27 1 . 39 30 . 32 . 48 . 03 
Mean 3 . 09 3 . 08 49 . 5  1 2 . 9 13 . 2  7 1 . 09 4 . 60 43 . 96 1 65 . 50 26 . 49 35 . l l  
1Red Bl ood Cel l s  x 10 o/mm 3. 4Hemog lobin Concentration . 7Mea n  Corpuscular Volume . 
2Whi te Blood Cel ls  x 10 3/rnm 3• 5Reticulocytes/100 Erythrocytes . 8Mea n Corpuscula r  Hemog l obin 
3Pa cked Cell  Volume . 6Mean  Corpuscular Hemog lobin . C oncentra tion . 
9rota l Body Weight . U1 
co 
RAW DATA TABLE V I  
GROUP II (DIBENZ\� INE ) FETUS SAMPLES 
Fetus RBCl WBC2 Pcv3 Hb4 Reticu l o - RBC P l a sma MCH6 f/CV7 !v'tCHC8 TBW9 
% g% cytes5 Fe Fe 
mg% mg% uug u3 % gm 
Doe 1 
No hemogram parameters ava i la bl e .  
Doe 2* 
1 2 . 40 0 . 67 38 . 0  9 . 7 17 . 2  29 . 06 10 . 61 40 . 50 156 . 58 .  25 . 88 30 . 56 
2 3 . 28 0 . 76 54 . 0  1 2 . 4  13 . 8  37 . 86 1 64 . 88 22 . 97 25 . 1 6 
Doe 3 ** 
1 3 . 47 1 . 24 48 . 0  1 2 . 1 18 . 2  89 . 27 4 . 02 34 . 87 138 . 34 25 . 21 40 . 76 
2 3 . 46 0 . 98 48 . 0  1 1 . 5  22 . 8  33 . 1 9 1 38 . 53 23 . 96 34 . 30 
3 3 . 74 1 . 40 5 1 . 0  1 3 . 4  21 . 7  35 . 92 1 36 . 18 26 . 38 44 . 42 
Doe 4*** 
i 4 .. 03 1 . 15 54 . 5  14 . 5  17 . 8  62 . 12 2 . 52 35 . 54 133 . 58 26 . 60 44 . 56 
2 3 . 94 4 . 07 . 5 1 . 5  12 . 8  20 . 3  32 . 32 1 30 . 54 24 . 76 37 . 56 
3 4 . 07 4 . 3 1 62 . 0  15 . 8 1 9 . 2  38 . 82 1 52 . 34 25 . 48 40 . 22 
4 4 . 00 1 . 46 57 . 0  1 5 . 5 14 . 7 38 . 12 142 . 50 26 . 76 39 . 1 8 
Doe 5**** 
1 3 . 74 1 . 1 6 49 . 0 1 2 . 0  . 1 8 . 4  47 . 05 14 . 76 32 . 09 131 . 02 24 . 49 37 . 78 
Mean  3 . 62 1 . 72 51 . 3  1 3 . 0  18 . 4  56 . 88 7 . 98 35 . 92 142 . 45 25 . 25 37 . 45 
lRed Blood Ce l l s  x 106/mm3 . 4Hemog l obin Conc;entra ti on . 7Mean  Corpuscular  Volume . 
2White Blood Cel l s  x io3/rnm3 • 5Reticul ocytes/J.OO Erythrocytes .  8Mean Corpuscu lar Hemog l obin 
3Pa cked Cel l Volume . 6Mea n Corpuscu l<: r  Hemog l obin . Concentra tion . 9rota l �ody Weight . 
*Doe 2 had three fetuses  with hydrocepha l isrn , of wh:..ch one died before hemogram parameters c ould  be 
c o l l ected . 
*7<-0ne fetus died in utero . 
***Six dead fetuses in utero . 
(J1 *�**Seven dead fetuses in utero . '° 
RAW DATA TABLE VI I 
GROUP I II (DIBENZYLINE + IRON ) FETUS SAMPLES 
Fetus RBcl WBc2 Pcv3 
% 
Hb4 Reticulo- RBC Pla sma f/CH6 Mcv7 
g% cytes5 Fe F e  . 
mg% mg% uug u3 
Doe i-x-
1 4 . 17 
2 3 .  72 
3 3 . 62 




l 3 . 75 
2 4 . 51  
3 3 . 05 
4 4 . 38 
Doe 4**** 
3 . 05 
1 . 0 6  
2 . 64 
2 .  72  
60 . 5  
57 . 5  
53 . 0 
48 . 0 
1 5 . 3  
14 . 5 
1 3 . 6 
1 2 . 0 
parameters ava i la bl e . 
1 - 32 
1 . 37 
1 . 56 
4 . 24 
55 . 0  
60 . 0  
45 . 0  
64 . 0  
14 . 6  
1 5 . 5  
1 1 . 7 
16 . 4  
8 . 9  
17 . 2  
22 . 6  
1 8 . 3  
9 . 4 
1 2 . 2 
1 1 . 2  
23 . 4  
1 2 . 84 1 . 7 1  40 . 0  10 . 0  25 . 2  
2 No hemogram parameter s ava il able . **** 
3 No hemogram parameters ava i l able . **** 
Doe 5 
l "  3 .  50 
2 3 . 36 
Mean  3 . 62 
2 . 49 
1 . 32 
2 . 1 5  
53 . 5  
49 . 5  
53 . 2  
13 . 6  
13 . 1  
1 3 . 7  
24 . 4  
31 . 9  
1 8 . 6  
69 . 92 2 . 89 
64 . 08 4 . 69 
48 .. 89 2 .. 84 
39 . 3 1 8 . 52 
55 . 55 4 . 74 
36 . 69 
39 . 36 
37 . 52 
40 . 44 
38 . 94 
34 .. 38 
38 . 36 
37 . 44 
35 . 22 
38 . 80 
39 . 04 
37 . 84 
143 . 88 
157 .. 40 
146 . 22 
1 62 . 44 
146 . 67 
133 . 06 
147 . 54 
146 . 12 
140 . 86 
1 52 . 64 
147 . 54 
147 . 67 
MCHC8 
% 
25 . 50 
25 . 00 
25 . 66 
24 . 90 
26 . 55 
25 . 83 
25 . 75 
25 . 62 
25 . 00 
25 . 42 
26 . 46 
25 . 61 
TBW9 
gm 
32 . 88 
33 . 96 
37 .. 76  
45 . 87 
38 . 26 
38 . 18 
42 . 23 
45 . 87 
23 .. 1 8  
1 8 . 87 
1 8 . 54 
31 . 7 1  
33 . 58 
33 . 91 
lRed Bl ood Ce l l s  x io6/nm13 . 
2Whi te Bl ood Cel l s  x 103/mm3 . 
3Pa cked Cel l Volume . 
4Hemoglobin Concentra tion . 
5Reticul ocytes/100 Erythrocytes . 
6Mean Corpuscular Hemog l obin . 
7Mean  Corpuscular  Vo lume . 
8Mean C orpuscular Hemog l obin 
Concentra tion . 
*F ive fetuses died in utero . 
**Aborted f ive fetuses . 
***one fetus died in utero . 
9Tota l Body We ight . 
-X-7<-**Two fetuses died before sampfos  -could be c o l l ec ted a 1 d s ix fetuses  d ied in utero . ()\ 0 
RAW DATA TABLE VI I I  
GROUP I V  · ( ATROP I NE )  FETUS SAMPLE S  
F e tu s RBC l vmc2 Pcv3 Hb4 Retic u l e - RBC P l a sma f!CH6 'fl.CV 7 JVCHC8 TBW9 
% g% c yt e s5 F e  F e  
mg% mg% uug u3 % gm 
D o e  l* 
1 2 . 98 0 . 95 50 . 0  1 2 . 9 13 . 0  57 . 20 1 . 63 43 . 36 1 68 . 07 25 . 80 3 2  .. 0 2  
2 2 . 8 6 1 . 44 45 . 0  1 1 . 5  1 3 . 0  40 . 20 1 57 . 36 25 . 56 35 . 04 
3 2 . 67 3 . 20 45 .·o 1 1 . 8  1 1 . 6  44 . 20 1 68 . 54 26 . 22 3 3  .. 99 
4 3 .  76  1 . 07 53 . 0  1 4 . 8  1 3 . 2 3 9 . 41 141 . 14 27 . 92 32 . 7 � 
5 3 . 1 8 1 . 34 54 . 0 1 3 . 6  17 . 4  42 . 99 1 70 . 1 0 25 . 28 29 . 87 
6 3 . 82 1 . 90 53 . 0 14 . 2  1 5 . 2  37 . 1 2 1 3 8 . 5 6 26 . 7 9 3 6 . 26 
7 2 .  74 2 . 26 49 . 0  1 3 . 1 14 . 5  47 . 90 1 7 9 . 1 6 26 . 73 3 0 . 88 
D o e  2 
l 2 . 41 1 . 60 41 . 0 1 0 . 0  4 . 1 65 . 34 1 6 . 29 41 . 49 1 70 . 1 2 24 . 3 9 26 . 21 
2 3 . 00 2 . 93 41 . 5  1 1 . 3  17 . 2 37 . 60 1 38 . 10 27 . 23 33 . 65 
3 2 . 90 1 . 90 46 . 5  1 2 . 0  5 . 6  4 1 . 3 8 1 60 . 34 25 . 8 1 3 1 . 55 
D o e  3-
1 3 . 86 1 . 1 8  53 . 0  1 3 . 4  21 . 2  58 . 78 3 . 0 1 34 . 54 1 37 . 1 3 25 . 1 9 40 . 45 
2. 2 . 57 5 . 56 41 . 0  1 0 . 4  14 . 3 40 . 46 1 5 9 . 54 25 . 37 1 8 . 82 
3 2 . 84 8 . 60 47 . 0  1 1 . 6  17 . 0  40 . 84 i 65 - 50 24 . 68 . .  3 2 . 25 
4 3 . 47 7 . 34 49 . 0  1 2 . 9  20 . 4  37 . 1 6 141 . 22 26 . 32 37 . 50 
5 2 . 83 4 . 51 44 . 0  1 1 . 4  2 1 . 0  40 . 28 1 5 5 . 48 25 . 91 26 . 82 
D o e  4 
N o  hemogram parameters a va i l a bl e .  
D o e  5 
1 4 . 08 2 . 24 55 . 0 14 . 2  3 1 . l  1 0 . 4L 1 . 32 34 . 76 1 34 . 64 25 . 82 40 . 3 9 
Mea n 3 . 1 2 3 . 00 47 . 9  1 2 . 4  1 5 . 6  47 . 94 5 . 56 40 . 23 1 55 . 3 1 . 25 . 94 3 2 . t10 
*
one f e tu s  d ied in utero . 
Q'\ 
1--' 
RAW DATA .TABLE IX 
GROUP V ( ATROPINE + IRON ) FETUS SAMPLES 
Fetus  RBci woc2 rcv3 Hb4 Reticu lo - RBC P l a sma MCH6 MCV7 MCHC8 TBW9 
% g% cytes5 Fe Fe 
mg% mg% uug u3 % gm 
Doe 1 
1 3 . 36 1 . 78 52 . 0  1 4 . 0  9 . 0  49 . 7 1  4 . 48 4L 60 1 54 . 5 2 26 . 92 37 . 7 2 
2 2 . 70 1 . 34 40 . 5  1 1 . 3  14 . 5  41 . 85 1 5 0 . 00 27 . 90 35 . 37 
3 2 . 94 1 . 1 0 43 .. 0 1 1 . 5  7 . 8  3 9 . 1 8  146 . 52 26 . 7 6  34 . 98 
4 3 . 21 1 . 28 49 . 0  1 3 . 1  1 2 . 6  40 . 8 1 152 . 65 27 . 73 38 . 26 
5 3 . 25 1 . 1 0 49 . 0  1 3 . 1  1 2 . 2  40 . 30 1 50 . 77 26 . 74 4 1 . 90 
6 3 . 50 1 . 35 49 . 0  1 3 . 1  10 . 8  37 . 38 1 3 9 . 80 26 . 73 3 2 . 98 
Doe 2** 
1 3 . 21 1 . 20 46 . 0  1 2 . 6  5 . 4  27 . 40 3 . 20 3 9 . 10 1 43 . 30 27 . 28 29 . 13 
2 3 . 40 1 . 96 53 . 0  1 4 . 6  7 . 4 43 . 0 1 1 5 6 . 1 3 27 . 55 33 . 1 4 
3 2 . 96 1 . 78 52 . 0  1 4 . 0  1 7 . 2  47 . 38 175 . 98 26 . 92 3 L 29 
4 3 . 56 1 . 09 49 . 0  1 3 . 0  1 4 . 9  3 6 . 38 1 37 . 64 26 . 42 30 . 9 1 
5 2 . 76 1 . 22 49 . 0  1 2 . 7  1 1 . 0  46 . 02 177 . 54 25 . 92 26 . 08 
Doe 3*** 
1 3 . 74 1 . 1 8 52 . 0  1 3 . 1  3 . 4  7 . 0 1  1 . 20 35 . 02 1 3 9 . 04 25 . 1 9 37 . 3 6 
Doe 4 
No hemogram parameters ava ilabl e . 
Doe 5 
1 3 . 77 7 . 1 2 53 . 0  1 4 . 1  · 20 . 6 7 2 . 57 4 . 17 37 . 40 1 40 . 58 26 . 60 3 9 . 7 1 
2 3 . 74 2 . 1 2 52 . 0  1 3 . 6  1 6 . 1  3 6 . 47 1 3 8 . 9 1 26 . 25 28 . 54 
3 3 . 73 2 . 96 57 . 0  1 4 . 6 1 4 . 4  39 . 00 1 5 2 . 82 25 . 52 3 2  .. 1 4  
4 3 . 92 2 . 3 9 56 . 0  14 . 6  14 . 2  37 . 17 1 43 . 04 25 . 98 3 2 . 7 9 
5 3 . 46 2 . 52 5 1 . 0  1 3 . 2  15 . 8  38 . 1 2 1 47 . 1 8 25 . 90 24 . 67 
Mean 3 . 37 1 . 97 50 . 1  1 3 . 3  1 2 . 2 39 . 17 3 . 26 3 9 .  7 8  149 . 7 9 26 . 6 1 33 . 35 
*one fetus died in utero . 
**on e  mummi fied fetus . 
***Two mummif ied fetuses . °' 
f\) 
RAW D,HA TABLE X 
GROUP VI (DIBENZYLINE + ATROPINE + IRON ) FETUS SAMPLES 




* Doe 1 
1 3 . 65 3 . 27 -47 . o  1 1 . 9  
Doe 2 
No hemogram parameters ava i lable . 
Doe 3 ** 
1 4 . 08 2 . 53 56 . 0 14 . 4  
2 4 . 66 4 . 24 63 . 0  1 6 . 6  
3 3 . 84 1 . 84 53 . 0  13 . 7  
Doe 4 
No hemogram parameters a va i la bl e .  
Doe 5 
No· hemogram parameters ava il able . 
Mean 
lRed Bl ood Cel l s  x io6/rrrn3 • 
2White Bl ood Cel l s  x io3/mm3 • 
3Pa cked Cell  Volume . 
. *Seven fetuses d ied in utero . 
**Four fetuses  died in utero . 
Reti c u l e - RBC P l a sma MCH6 
cytes5 Fe Fe 
o/ mgp mg% uug 
17 . 3  s . 1 2 2 . 50 32 . 60 
16 . 6  77 . 30 4 . 26 35 . 29 
15 . 6  35 . 66 
18 . 4  35 . 68 
4Hemog lobin Concentra tion . 
5Reticulocytes/100 Eryth�ocytes .  
6Mean Corpuscu l ar Hemog l obin . 
Mcv7 MCHC8 TBW9 
u3 % gm 
1 28 . 78 25 . 32 32 . 06 
1 37 . 25 25 . 72 28 . 80 
1 35 . 34 26 . 35 3 1 . 85 
1 3 8 . 02 25 . 85 32 . 26 
7Jviea n  Corpuscular Volume . 
8Mean Corpuscular He�og l obin 
Concentra tion . 




f'ltEAN PRE -TREATMENT DOE HEMCGRAM VALUES 
Group We ight RBCl WBC2 Pcv3 Hb4 Ret icu lo- RBC Pla sma MCH6 f'flCV7 MCHC8 
gm % g% cytes5 Fe Fe 
mg% rng% uug u3 % 
I 2291 5 . 09 5 . 21 39 . 0 1 2 . 9 2 . 9  49 . 78 2 . 04 25 . 76 78 . 1 0 33 . 04 
I I  2056 6 . 22 7 . 17 41 . 2 13 . 2  4 . 0  50 . 02 1 . 58 2L 21 66 . 26 3 1 . 96 
I I I  2243 5 . 27 . 6 . 3 6 37 . 0 1 1 . 9  3 . 9  5 1 . 92 1 . 30 21 . 7 6  6 9 . 1 1 3 1 . 59 
IV 2284 5 . 25 5 . 67 41 . 3  1 2 . 7  2 . 6  48 . 90 1 . 55 25 . 1 5 77 . 77 32 . 36 
v 2202 5 . 64 6 . 27 40 . 2  13 . 5 2 . 8  5 1 . 55 1 . 64 23 . 3 1 71 . 45 3 2 .  60 . 
VI  1 878 6 . 82 9 . 46 43 . 0  13 . 7  3 . 3  48 .. 03 1 . 64 23 . 3 1 72 .  79  3 1 . 95 
MEAN POST-TREATMENT DOE HEMCGRAM VALUES 
Group Weight RBC 1 WBC2 Pcv3 Hb4 Ret iculo- RBC Pla sma MCH6 f'flCV7 MCHC8 
gm % g% cytes5 Fe F e  
mg% mg% uug u3 % 
I 2337 4 . 37 4 . 36 36 . 2  1 1 . 5  1 . 6 47 . 52 1 .  70 26 . 82 84 . 33 - 3 1 . 8 6 
I I  2006 5 . 17 5 . 44 36 . 2 1 1 . 4  4 . 1  41 . 38 2 . 00 22 . 49 70 . 66 3 1 . 62 
I I I  2184 4 . 59 5 . 96 35 . 4 1 1 . 0 5 . 0  45 . 50 3 . 3 6 24 . 00 77 . 51 30 . 95 
IV 21 45 5 . 21 4 . 98 37 . 0  1 1 . 5  3 . 5  48 . 1 6 1 . 74 25 . 87 82 . 44 3 1 . 47 
v 21 28 4 . 94 7 . 00 3 9 . 1  12 . 1 4 . 6  48 . 56 1 . 98 24 . 65 7 9 . 5 1 3 1 . 0 1 
V I 1842 5 . 71 7 . 15 3 6 . 4  10 . 6  3 . 7 45 . 14 2 . 88 22 . 1 1 69 . 87 3 1 . 59 
lRed Bl ood Cel l s  x 10 6/mm 3. 5Reticulocytes/100 Erythrocytes . 
2Whi te Blood Cel l s  x 10 3/mm 3. 6Mean Corpuscu lar Hemog l obin . 
3Pa cked Cel l Volume . ?Mea n Corpuscular Volume . 
4Hemog lobin Concentra tion . 8Mea n  Corpuscular Hemog l obin Conc entration . 0\ 
� 
G roup Weight RBCl WBC2 Pcv3 
gm % 
I 35 . l l  3 . 09 3 . 08 49 . 5  
I I  37 . 45 3 . 62 . 1 . 72  5 1 . 3 
I I I  33 . 91 3.62 2 . 15 53 . 2  
I V  32.40 3 . 1 2 3 . 00 47 . 9  
v 33 . 35 3 . 37 1 . 97 50 . 1  
V I  3 1 . 24 4 . 06 2 . 97 54 . 8 
lRed Blood Cel l s  x io6/mrn3. 
2wh ite Blood Cei l s  x 103/mm3 . 
3Packed Cel l  Volume . 
4Hemog lobin Concentration . 
TABLE XI I  
MEAN FETAL HE MCGRAM VAL UES 
Hb4 Ret icu l o - RBC Pla sma MCH6 f!CV7 MCHCB 
g% cytes5 Fe Fe 
mg% mg% uug u3 % 
1 2 . 9 1 3 . 2  71 . 09 4 . 60 43 . 96 1 65 . 50 26 .49 
1 3 . 0  18 . 4  56 . 88 7 . 97 35 , 92 142 . 45 25 . 25 
1 3 . 7  18 . 6  55.55 4 . 74 37 . 84 147 . 67 25 . 61 
1 2 . 4  15.6 47 . 94 5.56 40 . 23 155.31 25 . 94 
1 3 . 3  12 . 2  39 . 17 3 . 26 39 . 78 149 . 79 26.61  
14 . 2· 17 . 0  42 . 7 1  3 . 38 34 . 81 134 . 85 25 . 81 
5Reticulocytes/100 Erythrocytes . 
6Mean Corpuscular Hemog l obin . 
7Mea n  Corpuscular Volume . 
8Mea n Corpuscular Hemog l obin Concentra tion . 
°' 
(J1 
